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ABSTRACT
Stem cells exist in various tissues, including dental follicles and dental pulps. Adult stem
cells (ASC) can be isolated from patients for autologous transplantation, which eliminates the
risk of immune rejection with low or no tumorigenesis. However, one of the challenges is that
ASC progressively lose their differentiation ability when cultured in vitro. This prevents
expansion of large quantities of high-potential stem cells for therapeutics, especially for stem
cells with limited tissue source, such as dental pulp stem cells (DPSC). The goal of this study is
to define possible molecular regulation causing loss of differentiation. To achieve this goal, we
determined that DPSC at passages 3 and 5 (early passage) possessed strong differentiation
capability, and such differentiation capability is completely lost at passage 11 (late passage).
Using whole-genome microarray to compare the transcriptomes, we found that the
expression of 34 genes were decreased for more than 10-fold in p11 DPSC when compared to
p3. After confirming gene expression with RT-PCR, heat shock protein B8 (HspB8) and the
GIPC PDZ domain-containing family (Gipc2) were selected for siRNA knockdown study.
Knockdown of HspB8 in early-passage DPSC resulted in the cells losing differentiation, but
knockdown of Gipc2 had no effect, suggesting that HspB8 plays an important role in maintaining
DPSC differentiation. To further study HspB8, we constructed 2 vectors, one containing the
coding sequence (CDS) and 3’ untranslated region (3’UTR) and another containing only the
CDS. Transfection of the vectors into early passage DPSC dramatically increased both HspB8
mRNA and protein. However, transfection of the vectors into the late passage DPSC resulted in
overexpression of HspB8 mRNA, but increase of HspB8 protein was seen only in CDS
transfection. Given that 3’UTR of mRNA is the major target region for microRNAs (miRNAs),
the results indicate that miRNAs are responsible for down-regulation of HspB8 in long-term
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culture of DPSCs. We conclude that high-level HspB8 expression is essential for differentiation
of DPSC, and down-regulation of HspB8 in cultured DPSC is likely due to increased expression
of miRNAs. These are novel findings regarding HspB8 and miRNAs on the regulation of stem
cell fate.
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CHAPTER 1: STEM CELLS AND DENTAL PULP STEM CELLS FOR RESEARCH
AND THERAPY
1.1 INTRODUCTION
Stem cells are undifferentiated cells which possess the abilities of self-renewal and
differentiation into specialized cells. These two abilities make them attractive for therapeutic
applications, such as regeneration of diseased and injured organs and tissues. The earliest form of
stem cell therapy was the use of transplanted bone marrow to restore hematopoiesis in irradiated
bone tissue [1-3]. Currently, bone marrow transplant is still an effective method to restore
hematopoiesis for treatment of leukemia [4, 5]. Recent studies have shown that stem cells can
move towards tumors (i.e. tumor-tropism), and the usefulness of stem cells as vectors for
targeted delivery of therapeutic agents to cancers is currently under investigation [6-9]. Besides
therapeutic applications, stem cells also provide a useful model to study tissue development [10].
Stem cells existing in nature can be classified into two major categories, according to
their tissue origins: embryonic stem cells (ESC) and adult stem cells (ASC). As their names
suggest, ESC are derived from tissues found during embryonic development, specifically in the
blastocyst at the early stages of development. ESC possess strong capabilities of self-renewal and
differentiation capabilities. They are pluripotent – meaning they can differentiate into cell types
of any germ layer [11, 12]. Another important characteristic of ESC is that they can be
maintained and proliferated in vitro for an indefinite time without losing their stem cell
properties of self-renewal and differentiation capability. However, there are a number of
technical and ethical issues in using ESC. One of the major drawbacks in the use of ESC is
immune rejection because autologous transplantation of ESC is not possible. Use of ESC
presents an elevated risk of tumorigenesis after transplantation into patients [13]. In addition,
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isolation of ESC requires destruction of embryos, which raises issues on both ethical and legal
fronts [14, 15].
In contrast to ESC, ASC are derived from adult tissues, and studies suggest that stem
cells exist in most, if not all, adult tissues. ASC possess several advantages. They can be
harvested from the patient’s tissues and used for that same patient for autologous transplantation.
Another major advantage of autologous stem cell transplantation is that it does not cause immune
rejection. ASC are multipotent – they can differentiate into limited cell types. This limited
potency allows ASC to differentiate into a unique cell type easily after transplantation. Another
important feature of ASC is their low tumorigenicity. Transplantation of ASC does not result in
teratoma formation, which is a risk associated with transplantation of ESC [13]. However, one
major drawback of ASC is that their differentiation property cannot be maintained for long
period of time in vitro; i.e. ASC reduce or lose their differentiation capability during in vitro
expansion [16, 17]. Primary isolated ASC can be used for only a few passages before their
differentiation potential is lost. A large quantity of high potential ASC cannot be obtained
through continuous expansion of the primary isolated cells. Thus, loss of differentiation hampers
their therapeutic applications.
Besides naturally-occurring stem cells, a third category of stem cells are artificial stem
cells, which include the induced-pluripotent stem cells (iPS) [18, 19] and stem cells from somatic
nuclear transfer (SCNT) [20]. The iPS cells are produced by introducing key transcription factors
(TFs) into somatic cells, which reprogram those cells to behave similarly to ESC. This technique
was first demonstrated in fibroblasts of mouse [18] and human origin [19]. The transcription
factors used for such transformation are Oct3/4, Sox2, Klf4, and c-Myc. Initially, introduction of
these genes required the use of viral transfection methods [18]. However, this technique
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presented its own set of challenges, as these TFs are oncogenic, and may produce more harm
than good if left unchecked [21, 22]. More recent studies have successfully generated iPS cells
without the use of viral vectors, allowing the removal of these genes after reprogramming [2325].
Stem cells from SCNT represent another attractive area as patient-specific cells can be
generated, and harvesting such cells raises less ethical issues. These cells are generated through
the insertion of somatic cell nuclei into the cytoplasm of an enucleated oocyte [26], a technique
that had previously been performed using the nuclei of ES cells [27]. These newly formed cells
are capable of blastocyst formation, from which stem cells can be harvested. When the
blastocysts are transplanted into a surrogate mother, they can potentially form viable offspring
[26]. However, developing stem cells using SCNT is unreliable, with successful stem cell
formation occurring 1-2% of the time in mice [28]. Moreover, since SCNT requires the use of
oocytes, developing human stem cell lines with this technique requires the addressing of ethical
and legal problems [29], which are not unlike the problems faced with isolation of human ESC
[14, 15].
1.2 DENTAL STEM CELLS
Obtaining adult tissues for stem cell isolation usually requires some invasive procedures.
However, teeth are often extracted and discarded as medical waste in dental treatment, and
human deciduous teeth are exfoliated. Use of these teeth for isolation of dental tissue stem cells
does not require additional surgical procedures. Thus, they provide an attractive resource of
tissues for isolating stem cells [30].
Stem cells have been isolated from various dental tissues. The dental follicle, a
connective tissue sac surrounding the unerupted tooth, has been used to isolate dental follicle
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stem cells (DFSC) [31-34]. DFSC have been shown to differentiate into calcium-depositing
cementoblasts/osteoblasts, adipocytes, and multipolar neurons in vitro [32]. Transplantation of
DFSC in vivo into mice yields cementum-producing tissue [35] and results in cementum
formation [36]. Moreover, DFSC could differentiate into periodontal ligament [37], which is
responsible for anchoring the mature tooth to the surrounding alveolar bone.
Stem cells are also isolated from the dental pulp, which arises from the neural crest
during tooth development [38]. When isolated from deciduous teeth in humans, they are called
stem cells from human exfoliated deciduous teeth (SHED) [39, 40]. SHEDs are actually derived
from the pulp of human deciduous teeth [39], and are capable of differentiating into osteogenic,
odontogenic, and adipogenic cells, as well as neural tissue [40]. Due to the nature of deciduous
teeth, they provide a highly accessible and non-invasive tissue source for isolation of a special
type of dental pulp stem cells (DPSC).
Besides DFSC and DPSC, stem cells have been obtained from other dental tissues, such
as the periodontal ligament (PDLSC) [41], and the apical papilla of immature permanent teeth
[42]. PDLSC bear the STRO-1+ marker [41], a stem cell marker found in bone marrow-derived
stromal cells (MSC) and DPSC [40, 43-45]. They are capable of differentiating in vitro into
cementum-secreting cells, as well as adipocytes and collagen-secreting cells. In addition, in vivo
transplants of PDLSC were capable of forming periodontal ligament-like tissue [41]. Stem cells
from the apical papilla (SCAP) were first isolated by Sonoyama et al. in 2008, and were
determined to bear resemblance to DPSC [42]. At the same time, SCAP are CD24+, which makes
them distinct from CD24- DPSC [30]. Further studies show that SCAP are capable of
differentiating in vitro into osteoblast/odontoblasts, as well as adipocytes [46].
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1.3 DIFFERENTIATION AND THERAPEUTIC POTENTIAL OF DENTAL PULP
STEM CELLS
DPSC can differentiate into fibroblasts, osteoblasts, odontoblasts, and adipocytes [44,
47], as well as neurogenic and myogenic tissues in vitro [47]. A number of studies have
suggested the potential uses of DPSC in tissue regeneration. These cells display the ability to
grow dental-pulp-like tissue in a matrix of dentin [40, 44]. When grown on a perforated collagen
scaffold, human DPSC differentiate into odontoblast-like cells in the presence of DMP-1 [48], or
into dentin-like tissue in the presence of BMP2 [49]. Nam et al. showed that growth of human
DPSC on porous granules of calcium phosphate, even in the absence of induction, promoted
odontoblastic differentiation and dentin deposition [50]. When used in combination with a
collagen scaffold and DMP-1, DPSC have been shown to regenerate dentin in perforated canine
molars in vivo [51]. Additionally, DPSC can potentially be used for the repair or treatment of
non-dental tissues. DPSC in canines, as well as stem cells from deciduous canine teeth (DTSC)
were shown to develop into new bone when injected into mandible bone defects in vivo [52].
Nesti et al. have shown that human DPSC, when co-cultured with mesencephalic neurons,
attenuated neuronal destruction from 1-methyl-4-phenylpyridinium (MPP+) and rotenone [53].
Because both MPP+ and rotenone promote the disruption and death of dopaminergic neurons
[54] and are used for in vitro models to mimic the destruction of dopaminergic neurons that
occurs in Parkinson’s disease [55, 56], this result suggests that injection of DPSC may delay the
progress of neurodegenerative disorders, such as Parkinson’s disease. Other studies have shown
that SHEDs can enhance wound healing [57] and differentiate into neural progenitor cells [58]
and endothelial cells [59]. These studies provide strong evidence to demonstrate that dental pulp
stem cells are an attractive source of stem cells for regeneration of dental and non-dental tissues.
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1.4 DIFFICULTIES AND PROBLEMS IN APPLICATIONS OF ASC
The use of stem cells for tissue engineering or regeneration requires a large quantity of
stem cells. However, it is difficult or often impossible to obtain sufficient quantities of stem cells
from primary adult tissues due to the following reasons: First, the frequency of ASC in adult
tissues is very low – generally less than 0.1% of the cell population in any given adult tissue
[60]. Second, invasive procedures are usually required to obtain the tissues, and the use of small
amount of tissue for ASC isolation is desired. Finally, in many cases only a limited amount of
tissue is available. This is especially true for the dental tissues. For example, only a small amount
of dental pulp could be obtained from each tooth. As such, in vitro expansion of the primarily
isolated ASC is required to acquire sufficient cells for clinical applications. The complications
with in vitro expansion of ASC are twofold: first, the cells become senescent and lose their selfrenewal property after a certain number of cell doublings; and second, the cells gradually reduce
and ultimately lose their differentiation capability as cell passage increases. Thus, it is difficult,
often impossible, to obtain a sufficient quantity of high quality/potential ASC via in vitro
expansion, and this has greatly hampered the clinical application of ASC.
Loss of stem cell qualities during in vitro expansion or culture of ASC is a common
phenomenon. Various types of adult stromal cells demonstrate a loss of proliferation, termed
proliferative senescence [61]. Like any non-immortal somatic cell, ASC will become senescent
(non-dividing) after approximately 40-60 doublings [62].
In addition to a proliferative senescence, ASC also experience a decline in their capacity
to differentiate, which is termed functional senescence by Bonab et al. [63]. They observed a
20% decrease of differentiation into osteoblasts after 8 passages in cultured MSC. This reduction
progressed to a 25% decrease by p10. In addition, they reported that the decline in adipocyte
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differentiation occurred sooner [63]. Similar to other ASC, dental stem cells are capable of
differentiation within certain passages of in vitro culture [16, 17]. Takeda et al. reported that
human DPSC lose the ability to differentiate at various passages, depending on the desired
ultimate cell type. They reported a strong decrease from p3 to p10 in the activity of alkaline
phosphatase (ALP) [16], indicating the reduction of differentiation into osteoblasts and
odontoblast [40, 64]. In in vivo studies, DPSC could form dentin-like tissues when transplanted
at p4, however when p10 DPSC were transplanted, formation of dentin-like tissue was not
observed [16].
Stem cells lose their therapeutic value upon loss of their differentiation capability. ESC
can maintain their stem cell properties (self-renewal and differentiation capabilities) indefinitely
in vitro under proper conditions. This evokes a big question: is it possible to develop methods to
maintain the proliferation and differentiation capabilities of ASC? Studies have attempted to
delay the senescence and to prolong the differentiation capability of ASC by improving culture
medium. Gharibi and Hughes report that a great increase in proliferation and delayed senescence
of in vitro cultured mesenchymal stem cells (MSC) can be achieved by supplementing the
culture medium with basic fibroblast growth factor (FGF-2), platelet-derived growth factor
(PDGF)-bb, ascorbic acid (AA), and epidermal growth factor (EGF). However, this
supplementation did not delay the loss of differentiation. They also noticed that the loss of
differentiation was not reflected by any changes in stem cell surface marker expression [65].
1.5 MOLECULAR REGULATION OF STEM CELL PROPERTIES
Self-renewal and differentiation capabilities are the two fundamental properties of stem
cells. Studies have been attempted to elucidate the molecular regulations of such capabilities. Of
particular note are the genes of transcription factors such as Oct4, Sox2, and Nanog. These genes
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have been shown to maintain a pluripotent state in stem cells, and they are used to reprogram
somatic cells into stem cells. These genes are heavily regulated by a large number of other genes
[66-69]. Many other genes were also found to maintain stem cell properties. For example Esrrg
preserves the undifferentiated state [68], while Wnt genes promote ESC differentiation [70]. A
more thorough list of stem cell-related genes can be found in Table 1.1.
Micro-RNAs (miRNAs) are short, non-coding RNAs generated from genomic DNA that
bind to target mRNAs to exert post-transcriptional regulation (such as translational repression,
mRNA destabilization, and/or cleavage) via the RNA-induced silencing complex (RISC) (Figure
1.1). miRNAs have emerged as critical molecular regulators for maintaining the functions of
stem cells by fine tuning the protein levels of various factors [91]. A majority of the current
knowledge on miRNA regulation of stem cells was obtained from ESC, although the role of
miRNAs in regulating ASC was also explored. In hematopoietic stem cells (HSC), miRNA-128
(miR-128) and miR-181 are expressed to prevent differentiation, whereas miR-16, miR-103, and
miR-107 are expressed to prevent proliferation [92]. miRNAs have been reported to regulate
various forms of differentiation including monocytogenesis, myogenesis, cardiogenesis,
neurogenesis, and osteogenesis [91]. One study indicated that miR-125 inhibits osteoblast
differentiation by down-regulation of cell proliferation by an unknown mechanism [93]. Another
study revealed that osteogenic differentiation of adipose-derived stem cells was inhibited
because miR-26a down-regulated the translation of Smad mRNA, a transcription factor required
for osteogenesis [94]. These studies support the idea that miRNAs can function in maintaining
ASC fate in distinct ways.
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Table 1.1 Genes related to stem cell function
Gene
Stem Cell-Related Functions
Promotes expansion of human adipose-derived stem cells [71], induces
BMP4
trophoblast formation in human ESC [72]
c-Myc
Key factor in reprogramming adult fibroblasts into iPS cells [18, 19]
Nuclear receptor, part of Oct4 signaling network [66], maintains ES cells in
Dax1
undifferentiated state [73]
Dusp7

Knockdown induces differentiation of ES cells [68]

EGR1

Limits proliferation and migration of hematopoietic stem cells (HSC) [74]

Transcription factor in Oct4 signaling network [66], promotes self-renewal and
pluripotency by activating Oct4 expression [67]
FoxO1,3,4 Cell cycle arrest and quiescence [75]
Maintains pluripotency of P19 embryonal carcinoma cells, knockdown reduces
FoxM1
Oct4 and Nanog levels [76]
Promotes the differentiation of ES cells to germ-like precursor cell [77], promotes
KitL
differentiation of mast cells from hematopoietic stem cells [78]
Key factor in reprogramming adult fibroblasts into iPS cells [18, 19], maintains
Klf4
undifferentiated state of ESC [79]
Esrrb

Klf5

Maintains undifferentiated state of ESC [79, 80]

LIN 28

Can be used to reprogram iPS cells from human somatic cells [81]
Knockdown reduces levels of Oct4, Sox2, and Nanog, knockdown induces
differentiation of ES cells [68]
Maintains pluripotency of ES cells [82]
Key factor in reprogramming adult fibroblasts into iPS cells [18, 19]
Part of Oct4 signaling network [66], binds to Nanog and Sox2 in ES cells [83]
Key factor in reprogramming adult fibroblasts into iPS cells [18, 19], essential for
maintaining ES cells [84]
Transcription factor in Oct4 signaling network [66]
Knockdown reduces levels of Oct4, Sox2, and Nanog, knockdown induces
differentiation of ES cells, overexpression reduces ES cell differentiation [68]
Secreted non-canonical protein, interacts with Notch in embryonic HSC
specification [85], the isoform Wnt16B is a marker for senescence [86]
Promotes self-renewal of ES cells through binding with Oct4 to promote Nanog
transcription [69]
Member of Oct4 binding network [87], regulates differentiation in adult stem
cells [88]
Maintains chromatin structure in pluripotent cells [89], maintains pluripotency in
P19 embryonic carcinoma cells [90]

Mki67ip
Nanog
Oct4
Sall1
Sox2
Tcfcp2L1
Timp2
Wnt16
Zfp143
Zfp219
Zfp462
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Figure 1.1 Schematic illustration of biogenesis of miRNAs and post-transcriptional
regulation of gene expression in animal cells by a miRNA. 1. Transcription of DNA into
pri-miRNA; 2. Drosha processes pri-miRNA into pre-miRNA; 3. Nuclear exporting premiRNA; 4. Processing of pre-miRNA into miRNA duplex by dicer; 5. Formation of RNAinduced silencing complex (RISC) with guide strand; 6. RISC searches for matching mRNA,
7a. mRNA degradation when miRNA perfectly matching mRNA sequence, 7b. Translation
inhibition when miRNA partially matching mRNA; 7c. mRNA deadenylation
1.6 OBJECTIVES AND SIGNIFICANCE OF THIS DISSERTATION RESEARCH
Use of patient-specific stem cells for autologous transplantation in regenerative medicine
eliminates the risk of immune rejection after transplantation. DPSC are a valuable source of stem
10

cells for tissue engineering and regeneration. Studies have determined that DPSC can be induced
into specialized cells with strong calcium deposition capability, suggesting that DPSC would be
an attractive source of stem cells for regeneration related to bone and hard dental tissue. Yet, for
any given patient, teeth that can be used for stem cell isolation are limited, and isolation of large
quantities of stem cells from teeth is difficult. In vitro expansion of primarily isolated DPSC is
needed for therapeutic uses of such cells. Studies have also shown that DPSC reduce their
differentiation capabilities during in vitro culture [16, 17]. Thus, it is difficult to obtain large
amounts of high quality DPSC through in vitro expansion. The overall goal of this dissertation
research is to identify potential molecular regulation of the loss of differentiation capability in
DPSC. Our overall hypothesis is that reduced expression of certain genes causes the loss of
differentiation capability of DPSC during in vitro culture. The results of this study would aid in
understanding the mechanisms of loss of differentiation seen in dental stem cells, as well as in
other ASC. Elucidation of such a mechanism would facilitate the development of methods for
maintaining the stem cell properties of ASC in long-term culture. In turn, this would permit
growth of larger quantities of such cells for clinical applications. This is especially important for
DPSC, due to the small size of the dental pulp and limited source available for stem cell
isolation. Sufficient DPSC cannot be obtained from primary isolation. In vitro expansion of
primarily isolated DPSC is needed for therapeutic uses of such cells. It is ideal that primary
isolated high-differentiation potential DPSC can be expanded in vitro into large quantities
without the loss of this differentiation potential and saved for future autologous therapeutic
applications.
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CHAPTER 2: LOSS OF DIFFERENTIATION POTENTIAL IN DENTAL PULP STEM
CELLS DURING IN VITRO CULTURE
2.1 INTRODUCTION
Dental pulp stem cells (DPSC) are adult stem cells that were first isolated in human teeth
by Gronthos et al. in 2000 [1]. They share a number of similarities with bone marrow-derived
stromal cells (BMSC), such as the development of colony-forming unit-fibroblasts (CFU-F) in
vitro [2], or expression of stem cell markers, including VCAM-1, fibronectin, alkaline
phosphatase (ALP) [1], as well as the stromal cell marker STRO-1 [3, 4]. When transplanted in
vivo, DPSC have been shown to form dentin [1], as well as respond to in vitro induction into
neurogenic and myogenic tissues [5]. In mice, DPSC have been shown to possess neural crest
migration signals [6]. During embryonic development, these signals direct the migration of
cranial neural crest (CNC) cells towards the dental mesenchyme [7]. These cells have the
capability to differentiate into neuronal cells and glial cells, as well as the skeletal and connective
tissues of the head and neck [8]. Consistent with this finding are reports that DPSC possess
multi-differentiation in neural crest lineage for odontoblasts, chondrocytes, adipocytes [9, 10],
neural tissue [10, 11], and smooth muscles [10]. This multifaceted differentiation potential
makes DPSC valuable for regeneration of dental and non-dental tissues.
Like other ASC, the differentiation capability of DPSC is reduced when cultured in vitro.
Takeda et al. have shown that, when subjected to osteogenic induction in vitro, human DPSC are
capable of developing into calcium-depositing cells at early passages [12]. Transplantation of
early-passage DPSC in vivo yielded formation of dentin and pulp-like connective tissue that was
surrounded by a thin layer of odontoblast-like connective tissue. However, such differentiation
potential was reduced at passage 6 (p6) and total loss of differentiation was observed around p10
[12]. This research aims to determine the potential molecular regulation of the loss of
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differentiation using rat DPSCs. To achieve this goal, we first need to know the differentiation
potential of rat DPSC under our current culture conditions, such as when they start to lose the
differentiation potential, and when they completely lose the capability
Loss of differentiation under in vitro conditions mitigates the value of ASC. Various
studies have been attempted to preserve the differentiation potential of stem cells, such as the
addition of growth factors to culture medium [13]; however, the effect has been limited.
Elucidating the mechanism of the loss of differentiation would facilitate development of
techniques to preserve the differentiation potential of cultured stem cells. In searching the current
literature, we found little information on the topic. Takeda et al. found that, from early to late
passage, 719 genes had their expression levels reduced by half or more. In addition, they report
that an increase in Wnt16 is suspected to play a role in the loss of differentiation potential in
human DPSC [12].
Transcription factors (TFs) are DNA binding proteins that function to regulate expression
of various genes. The vital role of TFs has been demonstrated in reprogramming somatic nonstem cells into pluripotent stem cells through the introduction of key TFs [14, 15]. Given the
important roles of TFs, we speculate that TFs are involved in maintaining the differentiation
capability of DPSC. Thus, another objective of this chapter was to compare the expression of
selected stem cell-related TFs in the early and late DPSC to determine if these TFs change their
expression as the passages of DPSC advance.
It is generally accepted that ASC reduce overall differentiation potential as progression of
cell passages. However, one study showed that passage 9 (p9) DPSC presented greater
osteogenic differentiation than did p1 DPSC [16]. They concluded that this was because DPSC
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spontanenously underwent differentiation into an osteoblasts lineage in growth medium [16].
The last objective of this study was to clarify this controversy.
2.2 MATERIALS AND METHODS
2.2.1 Animals and Dental Pulp Collection
Sprague Dawley rats were handled in accordance with IACUC protocol. Dental pulps
were extracted from the first molars of 5-7 days old postnatal rats. Briefly, the mandibles were
surgically removed and surrounding soft tissues were cleaned off. First molars were removed
from the tooth crypt. The pulps were extracted from the molars and sliced into 1-2mm sections,
then transferred to a sterile tube filled with 5mL stem cell growth medium, i.e., MEM-α
supplemented with +20% fetal bovine serum (FBS) and antibiotics [17].
2.2.2 Establishment of Cell Cultures from Rat Dental Pulp
The tubes containing dental pulp tissues and medium were centrifuged at 3000rpm for 1
minute and media was aspirated. Next, 10mL of 1% trypsin-EDTA was added to suspend the
tissue pellet and incubated at 37°C for 10 minutes to obtain the cell suspension. After 5 minutes
of centrifugation, the trypsin was removed and the cell pellet was re-suspended in the appropriate
medium. For DPSC cultures, the cells were grown in stem cell growth medium consisting of αMEM, 20% fetal bovine serum (FBS), and antibiotics. Cells were incubated at 37°C and 5% CO2
in humidified incubators. At 90% confluence, cells were detached using trypsin-EDTA and
passaged to a fresh T-75 flask with an initial density of 200,000 cells per T-75 flask. For dental
pulp cell (DPC) culture, cells were grown in MEM with 10% newborn calf serum (NCS), 1mM
sodium pyruvate, and antibiotics as described by Wise et. al [18].
Established dental pulp-derived cells (DPSC and DPC) at p3 were tested for
differentiation (see section 2.2.3), and then processed for cryopreservation in liquid nitrogen for
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future experiments. Briefly, cells were detached from T-75 flasks and centrifuged at 3000rpm for
5 minutes, and medium was aspirated. Next, the cell pellet was re-suspended in freezing
medium, consisting of 50% stem cell growth medium, 40% FBS, and 10% dimethyl sulfoxide
(DMSO) to an approximate concentration of 5.0 x105 cells/mL. The cell suspension was
transferred to cryopreservation tubes and frozen at -80°C overnight before moving to liquid
nitrogen for long-term storage.
2.2.3 Assessment of Differentiation Capability of Dental Pulp Stem Cells
To assess if the established cells possess differentiation potential, both DPSC and DPC
were seeded to 6-well culture plates (10cm2) at a rate of 5 x 104 cells/well, with differentiation
medium consisting of low glucose DMEM (Gibco) supplemented with 10% FBS and
differentiation induction reagents (50μg/mL ascorbic acid, 100nM dexamethasone, and 10mM βglycerolphosphate) [17]. This medium has been reported to induce osteogenic differentiation of
various adult stem cells in several publications [17, 19, 20], including induction of osteogenesis
of dental follicle stem cells in our lab [21]. Cells incubated in the basal low-glucose DMEM
+10% FBS without the supplemented induction reagents were included as a control. In this
study, DPC and DPSC were incubated in the induction medium for 7 to 14 days, with medium
changes every 4 days. After the designated time of induction, calcium deposition was assessed
by Alizarin red staining [22]. For Alizarin red staining, cells were washed once with PBS and
then fixed in 10% neutral buffered formalin for 5 minutes. Cells were then washed in sterile
milli-Q H2O twice and stained in a 1% Alizarin red S solution for 20 minutes. Immediately
afterwards, cells were washed 4 times with sterile H2O. The degree of Alizarin Red staining was
graded with scales outlined in Table 2.1.
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For gene expression analysis, established DPC and DPSC were seeded in T-25 flasks
(25cm2) at a rate of 1.5 x 105 cells/flask in α-MEM+20% FBS and grown for designated times.
Next, the cells were collected into RLT buffer (Qiagen) for RNA isolation to compare gene
expression of selected stem cell-related TFs using real-time RT-PCR.
Table 2.1 Alizarin red staining scale
Grade Description
0

Complete absence of staining

1

Staining barely visible, or localized to only 1-3 small locations

2

Staining clearly observed, but covers less than 50% of the stained area

3

Staining observed in 50% or more of area, with only small areas of non-staining

4

Positive staining observed throughout the entire area

2.2.4 Experiments to Determine Differentiation Potential of Different Passages of DPSC
DPSC were recovered from liquid nitrogen, and cultured in T-25 flasks as described
earlier. Cells at 90% confluency were passaged into new flasks at a 1:3 ratio (i.e. 1 flask was
passaged to 3 flasks of the same size). Cells at passages 3, 5, 7, 9, and 11 were collected and
subjected to differentiation induction. Briefly, cells were seeded to sterile 6-well and T-25 flasks.
Differentiation induction was initiated when cells reached 80% confluence, as described in 2.2.3.
After 2 weeks of induction, cells were stained with Alizarin red or collected into RLT buffer for
gene expression analysis, as described in 2.2.3.
2.2.5 RNA Isolation
Cells were collected and lysed in RLT buffer, then centrifuged at 13000 rpm for 5
minutes. The supernatant was then collected and transferred to a fresh tube. Isolation was
performed using the RNeasy DNAse Digest kit (Qiagen). Briefly, the lysate was mixed with 70%
ethanol at a 1:1 ratio and transferred to a RNA-binding mini-spin column. The column was then
washed with RW1 buffer, followed by in-column DNAse I digestion (Qiagen) for 15 minutes.
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The column was washed again before elution with 30 μL nuclease-free water. Concentration of
RNA was determined using a Nanodrop 8000 (Thermo Scientific).
2.2.6. Reverse-Transcription and Quantitative Real-time PCR
M-MLV reverse transcriptase (Invitrogen) was used to generate a template strand of
cDNA from 1000-2000ng isolated total RNA. Each RNA sample was mixed with 250 ng random
primer in a 0.5 mL microtube and placed in a 65°C water bath for 5 minutes. The tube was
immediately transferred to ice for 2 minutes, followed by addition of reverse-transcription buffer
containing M-MLV reverse transcriptase. Reverse transcription was performed at 37°C for 50
minutes and followed by incubation at 70°C for 15 minutes to deactivate the reaction. The
resulting cDNA templates were then used for SYBR green real-time PCR to detect cycle
threshold (CT) in an Applied Biosystems 7300 sequence detector. Each reaction contained 1-2 μL
template cDNA, 12.5 μL of Power SYBR Green PCR Master Mix (Applied Biosystems), and
200 – 600 nM gene-specific primers in a total reaction volume of 25μL. A full list of primers
used for PCR is listed in Table 2.2. The CT of each gene was normalized to β-actin to obtain the
Table 2.2 Primers used in real-time RT-PCR
Gene
RefSeq
Primer Sequence
Forward: 5'-CTAAGGCCAACCGTGAAAAGAT-3'
Actin
NM_031144.3
Reverse: 5'-AGAGGCATACAGGGACAACACA-3'
Forward: 5'-GCTCCTGTTCCTGTCCCTAGT-3'
Ambn
NM_012900.1
Reverse: 5'-TTCCCAACTGTCTCATTGTCTC-3'
Forward: 5'-GAAAGACCCACGGGGATTAT-3'
BCRP
NM_181381.2
Reverse: 5'-CCCATCACAACGTCATCTTG-3'
Forward: 5'-TGATACCTGAGACCGGGAAG-3'
BMP4
NM_012827.2
Reverse: 5'-AGAAGTGTCGCCTCGAAGTC-3'
Forward: 5'-CTTACAGGAGCATCAGCACAGA-3'
BMP6
NM_133530.1
Reverse: 5'-GTCACCACCCACAGATTGCTA-3'
Forward: 5'-ACGCTGGAAAGTTGGAGTTAGCTG-3'
BSP
NM_012587.2
Reverse: 5'-TTCCTCTTCCTCGTCGCTTTCCTT-3'
Forward: 5'-AAAGGCCCCCAAGGTAGTTA-3'
c-MYC
NM_012603.2
Reverse: 5'-CTCGCCGTTTCCTCAGTAAG-3'
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(Table 2.2 continued)
Gene
RefSeq
Dax1

NM_053317.1

DMP1

NM_203493.3

DSPP

NM_012790.2

Dusp7

NM_001100547.1

EGR1

NM_012551.2

Esrrb

NM_001008516.2

FoxM1

NM_031633.3

FoxO1

NM_001191846.2

FoxO3

NM_001106395.1

FoxO4

NM_001106943.1

KitL

NM_021843.4,
NM_021843.4*

Klf4

NM_053713.1

Klf5

NM_053394.2

Lin28

NM_001109269.1

Mki67

NM_139186.2

Mmp13

NM_133530.1

Msh2

NM_031058.1

Mst1

NM_024352.1

Musashi

NM_148890.1

Primer Sequence
Forward: 5'-GAGCAGATCAAACACCAGCA-3'
Reverse: 5'-CCACCTGTGGATCCTTGAGT-3'
Forward: 5'-CCAGGACAGTAGCCGATCC-3'
Reverse: 5'-TTCAATGTTTTTGGGGTGGT-3'
Forward: 5'-GGGAAGCTCAGTGGAAGTAAAG-3'
Reverse: 5'-CTGCTGTGTCCCATGTTGTTAT-3'
Forward: 5'-CAGCCAATCTGGCAATTTTT-3'
Reverse: 5'-AACCAAGGAGAGCCTGAACA-3'
Forward: 5'-AACACTTTGTGGCCTGAACC-3'
Reverse: 5'-AGGCAGAGGAAGACGATGAA-3'
Forward: 5'-GTGCCTGAAGGGGATATCAA-3'
Reverse: 5'-AGAAACCTGGGATGTGCTTG-3'
Forward: 5'-GGAGCCTACTCAAGCACAGG-3'
Reverse: 5'-GGGATAGCCACCACTTGTGT-3'
Forward: 5'-AACCAGTCCAACTCGACCAC-3'
Reverse: 5'-TGCTCATAAAGTCGGTGCTG-3'
Forward: 5'-TCTCCCGTCAGCCAGTCTAT-3'
Reverse: 5'-GTCACTGGGGAACTTGTCGT-3'
Forward: 5'-CCTGGCCTACCCAGATTGTA-3'
Reverse: 5'-AAGGCAGCAGAAACCAGAAA-3'
Forward: 5'-GCTGTGAAACCTGCACTGAA-3'
Reverse: 5'-ATGGCGCAAGTAGACTGGAC-3'
Forward: 5'- GTGCAGCTTGCAGCAGTAAC-3'
Reverse: 5'- GTGGGATAGCGAGTTGGAAA-3'
Forward: 5'-ACCTACTTTCCCCCATCACC-3'
Reverse: 5'-TAGCAGCATAGGACGGAGGT-3'
Forward: 5'- CCCAGTGTCACCCTGTCTTT-3'
Reverse: 5'- TTCCCCACAAAAGCTTTCAC-3'
Forward: 5'-GGAAGAGCAAGCAGTGATCC-3'
Reverse: 5'-CCTGTCCATGTTTGCATGTC-3'
Forward: 5'-TTTATTGTTGCTGCCCATGA-3'
Reverse: 5'-GAGAGACTGGATTCCTTGAACG-3'
Forward: 5'-TGGATTCCACCCAGAGAAAG-3'
Reverse: 5'-TCTCTCCGCCTGGTAAAATG-3'
Forward: 5'-TACCATGGCTCAGGTGAACA-3'
Reverse: 5'-TGGGTGTGAATTGTGGCTTA-3'
Forward: 5'-TGCTGGGTATTGGCATGTTA-3'
Reverse: 5'-TAGGTGTAACCAGGGGCAAG-3'
25

(Table 2.2 continued)
Gene
RefSeq

Primer Sequence
Forward: 5'-TACCTCAGCCTCCAGCAGAT-3'
Nanog
NM_001100781.1
Reverse: 5'-CATTGGTTTTTCTGCCACCT-3'
Forward: 5'-CTCAACACACTGGGCTCTTTC-3'
Notch1
NM_001105721.1
Reverse: 5'-ACACCCTCATAACCTGGCATAC-3'
Forward: 5'-AGAACCGTGTGAGGTGGAAC-3'
Oct4
NM_001009178.2
Reverse: 5'-CACTCGAACCACATCCCTCT-3'
Forward: 5'-ACTGCATTCTGCCTCTCTGAC-3'
Ocn
NM_013414.1
Reverse: 5'-TATTCACCACCTTACTGCCCTCCT-3'
NM_001278483.1,
Forward: 5'-GCCGGGAATGATGAGAAC-3'
RunX2
NM_001278484.1** Reverse: 5'- GAGGATTTGTGAAGACCG -3'
Forward: 5'-GTGGCAAGGGTGAAGACAGT-3'
Sall1
NM_001107415.2
Reverse: 5'-ACAGAGGGTTGGTGAAGGTG-3'
Forward: 5'-ATTACCCGCAGCAAAATGAC-3'
Sox2
NM_001109181.1
Reverse: 5'-CTAGTCGGCATCACGGTTTT-3'
Forward: 5'-CCTACTTACCCGTCTGACTTTG-3'
Sp7
NM_001037632.1
Reverse: 5'-CAACTGCCTTGGGCTTATAGA-3'
Forward: 5'-GCTTGGCTTACGGACTGAGG-3'
Spp1
NM_012881.2
Reverse: 5'-GCAACTGGGATGACCTTGATA-3'
Forward: 5'-GGGACAGGACCAAAAGTCAA-3'
Tcfcp2L1 NM_001107170.1
Reverse: 5'-TGGGGTTCAAACACAGACAA-3'
Forward: 5'-GCATCACCCAGAAGAAGAGC-3'
Timp2
NM_021989.2
Reverse: 5'-GTCCATCCAGAGGCACTCAT-3'
Forward: 5'-GAGCTGTGCAAGAGGAAACC-3'
Wnt16
NM_001109223.1
Reverse: 5'-AGTGGCGACCATACAGTTCC-3'
Forward: 5'-AGCAGCCATCTCTGGAAGAA-3'
Zfp143
NM_001012169.1
Reverse: 5'-GAAAGGCTCTTCCTCCTGCT-3'
Forward: 5'-AGGAGAGTGGGCAAGCAATA-3'
Zfp219
NM_001007681.1
Reverse: 5'-CAGCAGCACATCCTCTACCA-3'
Forward: 5'-CAAGGCTCTGAGTGGGAAAG-3'
Zfp462
XM_342840.5
Reverse: 5'-CAGCTGCATACTGTCCTCCA-3'
* KitL mRNA has two separate isoforms, with isoform 2 having a slightly shorter CDS region, in
addition to the translated protein having slightly different C-terminus and being shorter than
isoform 1. The primers listed flank a conserved sequence.
**RunX2 mRNA has two separate isoforms, with isoform 2 having a shorter 5' untranslated
region and CDS region, as well as the translated protein having slightly different N-terminus and
being shorter than isoform 1. The primers listed flank a sequence conserved between the two
isoforms.
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ΔCT with the equation:

. We calculuated the difference in ΔCT between

experimental and control samples (ΔΔCT) using the equation:
.Relative gene expression (RGE) was calculated using the following equation:
[23]. The control was set to 1 with the standard error of the mean (SEM) of 0.
2.3 RESULTS
2.3.1 Growth Pattern of Dental Pulp Derived Cells
Two culture systems were used to culture cells derived from dental pulps. For DPSC
grown in stem cell medium, cultures reached 80% confluence 4-6 days after seeding. Earlypassage DPSC had a fibroblast-like appearance. Within 7-8 days, the cells reached 100%
confluence (Figure 2.1). As passaging progressed, DPSC morphology gradually transitioned to a
spindle-like shape, and cells were capable of forming colonies. In contrast, DPC grown in MEM
+ 10% NCS did not display the same fibroblast-like appearance. Cells reached 100% confluency
within 6 days, which was similar to DPSC, but they were not able to form colonies.

A – 1day

B – 3days

C – 5days

D – 7days

E – 9days

F – 11days

Figure 2.1 Culture and growth of early-passage DPSC. Note that DPSC reached full
confluency around 9 days of in vitro culture. Each frame represents to the same field of view
over the entire 11 days of culture. 100x magnification
27

2.3.2 Differentiation Capability of Dental Pulp Derived Cells
When both DPC and DPSC were incubated in differentiation-induction medium, Alizarin
red staining indicated that calcium deposits could be detected in DPSC as early as after 7 days of
induction. These calcium depositions were shown as scattered spots in the plate at day 7 (Figure
2.2; Section A). After 14 days of induction, the calcium deposits were spread to the entire plate
(Figure 2.2; Section B). In contrast to DPSC, DPC did not show any positive staining with

A

B

C

D

Figure 2.2 Comparing the differentiation capabilities of early-passage DPSC and DPC. Cells
were subjected to osteogenic induction for 1 or 2 weeks and stained with Alizarin red.
Positive staining was seen in DPSC as soon as 1 week (A), and increased staining was seen
after 2 weeks of induction (B). In contrast, no staining was observed in DPC after 1 or 2
weeks of induction (C and D). All images 50x magnification.
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Alizarin red after both 7 and 14 days of induction (Figure 2.2; Sections C & D), suggesting that
no stem cells were present in the DPC population.
Because calcium can be deposited by osteoblasts, odontoblasts, and/or ameloblasts, we
further assessed the expression of marker genes specific for osteoblasts (Bsp, Ocn, Runx2, Sp7,
Spp1), ondontoblasts (DSPP), and ameloblasts (Ambn) with real-time RT-PCR to assess the
differentiation lineage of DPSC. The results are shown in Figure 2.3. We observed an increase in
expression for marker genes of osteoblasts, odontoblasts, and ameloblasts after differentiation
induction. The greatest increase in expression occurred in Ocn, with a 10-fold increase after 7
days of induction, and an increase greater than 200-fold after 14 days. After 7 days of culture in
induction medium, Bsp expression appeared unchanged; however, its expression had increased
to 10-fold expression after 14 days of induction. This upregulation in expression after
differentiation was also observed for the other osteoblast markers Runx2 and Sp7. Expression of
the odontoblast marker DSPP increased sharply from 3-fold after 7 days to 112-fold after 14
days. Expression of the ameloblast marker Ambn had rapidly increased to 50-fold and 80-fold
after 7 and 14 days of induction, respectively (Figure 2.3). These results of marker gene
expression indicate that DPSC are capable of multipotent differentiation toward osteoblasts,
odontoblasts, and ameloblasts under our induction conditions.
2.3.3 Differentiation Potential of DPSC at Different Passages
To test the differentiation capability of DPSC during in vitro expansion/culture, the
DPSC were passaged at about 90% confluency, and different passages of cells were tested to
evaluate their differentiation capability, as detailed in Section 2.2.4. Gradual reduction of
calcium deposition was observed with progression of serial passaging, as shown by Alizarin red
staining. The representative images for each passage tested are reported in Figure 2.4. The
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Figure 2.3 Culture of DPSC in induction medium increases the expression of differentiation marker genes as determined by realtime RT-PCR
30

Figure 2.4 Reduced differentiation after induction of DPSC across serial passages, as determined by calcium deposition with
Alizarin red staining. Note that the gradual reduction of calcium-deposition in passages 3, 5 and 7 (A, B and C), and sharp
decrease of staining in passages 9 (D) and no staining at passage 11 (E). 50x magnification
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degree of staining was graded on a 0-4 scale as described in Table 2.1. Non-parametric statistical
analysis was conducted using the SAS program for analysis of variance (ANOVA) and least
significant difference (LSD). The results are presented in Figure 2.5. The results showed that p3
cells had a strong differentiation potential. Differentiation potential was somewhat reduced in p5
with no statistical difference, but significantly reduced at p7 (Figures 2.4, 2.5). However, by p9
and p11 their differentiation potential was dramatically reduced. Generally, no Alizarin red
staining could be seen in p11 DPSC after 14 days of induction, suggesting that the DPSC had
totally lost their differentiation capability by this passage. Based on the results of differentiation
potential, we classified p3 to p5 DPSC as early-passage DPSC, which possess strong
differentiation capability; and p9 to p11 as late-passage DPSC with significantly and greatly
reduced differentiation. capability. DPSC at p7 appeared as a transition passage before complete
loss of differentiation capability.

Figure 2.5 Reduction of differentiation capability in DPSC as cell passage increases. Note
that cells significantly reduced differentiation at p7 as compared to p3, and almost completely
lost differentiation after p9. Groups that do not share the same letter are statistically
significant at P<0.05 (mean ± SEM, n=3).
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2.3.4 Loss of Differentiation in DPSC Was Not Due to Overgrowth of DPC
The above experiments showed that DPSC gradually reduced their differentiation
capability during in vitro culture, and by p11 they no longer responded to differentiation
induction, which is similar to non-stem cell DPC. Because established DPSC were
heterogeneous, likely to contain non-stem cells in the population, there was a concern if the loss
of differentiation seen in the late passage DPSC was due to overgrowth of non-stem cell DPC.
To address this concern, we observed that the morphology of the two cell populations remained
distinct, as depicted in Figure 2.6. We further compared the expression of some stem cell marker
genes in early and late passages DPSC vs. DPC under the same culture condition. These results
are shown in Figure 2.7. We found that many of these marker genes, including Esrrb, DMP1,
Musashi, and Kit ligand (KitL), retained a high level of expression in late-passage DPSC, which
were similar to early passage. More importantly, expression of those genes was generally more
than 10 to 100-fold higher in late-passage DPSC as compared to DPC (Figure 2.7), suggesting
that the late-passage DPSC and non-stem cell DPC were distinct populations.
Comparing the early and late passages of DPSC, we found no significant changes in
expression of most of the stem cell marker genes tested such as Esrrb, DMP1, Musashi, and
KitL. However, significant changes of expression of ALP, Notch1, and BCRP were observed
when comparing the early passage to late passage. Of these, decreased expression of ALP and
BCRP in the late passage was observed.
2.3.5 Expression of Transcription Factors in Different Passages of DPSC
To study the possible transcription factors (TFs) that may be responsible for the loss of
differentiation in DPSC, a total of 30 TFs associated with stem cell function (see Table 2.2) were
screened for expression of the transcription factors and selected stem cell related genes in the
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Figure 2.6 Comparing the morphological differences between late-passage DPSC (A) and non-stem DPC (B). 50x magnification
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Figure 2.7 Expression of stem cell marker genes in early, late-passage DPSC and DPC. RGE was normalized to gene
expression in DPC (Y-axis is log10 scale, mean ± SEM, n=3, * indicates statistical significance of p < 0.05).
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early and late passage DPSC using real-time RT-PCR. Our objective was to determine a change
in expression of these genes in late passage DPSC when compared to the earlier passages. The
majority of the genes screened did not show any noticeable change between early and late
passage DPSC (data not shown). The most notable decrease-in-expression genes in late-passage
DPSC are displayed in Figure 2.8. Although the genes Klf5, Tcfcp2L1, and Zfp462 showed
differences, no statistical significance was detected in those genes by ANOVA and LSD. We
observed huge variations in expression of some of the genes among different batch of DPSC as
reflected by large error bars (Figure 2.8).
2.4 DISCUSSION
Alizarin red has been used to stain calcium deposition in many labs. When subjecting
early-passage DPSC to differentiation induction medium, strong calcium deposition was detected
after 2 weeks of culture as revealed by Alizarin red staining, suggesting that the cells had
differentiated into calcium-depositing cells. Because osteoblasts, odontoblasts, and ameloblasts
are all capable of depositing calcium, Alizarin red staining alone could not determine if the
DPSC were induced to differentiate into a particular type of calcium-depositing cells. Thus, we
examined the expression of marker genes in these DPSC-derived calcium depositing cells, and
we found that expression of the markers for osteoblasts, odontoblasts, and ameloblasts was
dramatically increased after differentiation induction. Increased expression of these
differentiation markers indicates that DPSC were capable of differentiating into osteoblasts,
odontoblasts, and ameloblasts. Studies by others have shown that colonies derived from human
DPSC show a diversity in cell surface markers, suggesting that DPSC cultures are
heterogeneous, containing different populations of cells [1]. Thus, it is also possible that
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Figure 2.8 Comparison of the expression of TFs and stem cell-related genes in early and
late-passage DPSC. No statistically significant change in expression of the transcription
factors was observed (mean ± SEM, n=6)
osteoblastogenesis, odontoblastogenesis, and ameloblastogenesis are the result of differentiation
of different subpopulations of stem cells existing in DPSC.
Loss of differentiation has been reported in long-term culture of stem cells derived from
different types of tissues. This cellular aging has been observed in hematopoietic stem cells in
mice [24]. In humans, bone marrow stromal/stem cells (BMSC) demonstrate a change in
morphology, from a fibroblast-like spindle shape to a flat, broadened shape, after 34 – 42
doublings in vitro, resulting in decreased differentiation of these cells [25]. Many studies
reported that BMSC largely lose their in vitro differentiation capability around p6 [26, 27], but
some studies have shown that differentiation reduction could occur as early as the first [28] or
second passage [29]. Wall et al. found that stem cells derived from human adipose tissue lose the
ability to differentiate into adipocytes as cells reach p10 [30]. It should be noted that not all ASC
experience this loss of function at the same rate. For example, MSC isolated from human
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umbilical cord can be grown in vitro for a longer period than those isolated from bone marrow
[31]. This study revealed that, similar to other ASC, DPSC start to reduce differentiation
capability at p7, and largely or completely lose differentiation around p11 (Figures 2.4, 2.5).
By p11, DPSC were not capable of differentiating into calcium depositing cells (Figures
2.4, 2.5) when subjected to induction. However, the expression of stem cell markers remained
constant in early and later passages, and expression was much higher than in non-stem cell DPC.
The results of our experiments indicate that the cells did not undergo spontaneous differentiation
in the medium without ascorbic acid, dexamethasone, and β-glycerolphosphate. This result was
inconsistent with the observations of Yu et al, who reported that DPSC underwent spontaneous
differentiation into osteoblasts [16]. After reviewing the experiments of Yu et al, we found that
although they used similar medium for establishing and maintaining DPSC, their medium
contained ascorbic acid and bovine pituitary extract [16]. Ascorbic acid is one of the reagents
used for inducing osteogenic differentiation [18]. Thus, it is likely that supplementation of
ascorbic acid in the medium induced differentiation, while the effect of bovine pituitary extract
could not be excluded.
Individual colonies derived from single cells in the DPSC tested positive for different
surface proteins, suggesting that DPSC are a heterogeneous cell population, containing different
cell types [1]. Because the majority of the cells in the dental pulp are non-stem cells, it is not
surprising that the primary isolated DPSC contained non-stem cells. One may ask if the
reduction or loss of differentiation seen in the late passages was due to overgrowth of non-stem
cells, such that they might become predominant in the late-passage DPSC population after longterm culture. To address this concern, we compared the expression of common stem cell markers
and found that most markers did not significantly change their expression in later passages, as
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compared to early passage. More importantly, comparing the late passage DPSC to their
counterpart non-stem cell DPC, we found that expression of these stem cell marker genes was
much higher in late-passage DPSC than in DPC (Figure 2.7). In addition, they also displayed
distinct cell morphology (Figure 2.6). Thus, the results of this study provide evidence that the
loss of differentiation potential in the late passage DPSC was not due to overgrowth of non-stem
cells, and loss of differentiation capability was likely due to intrinsic changes.
To further explore the intrinsic changes in DPSC that may cause the loss of
differentiation, we studied the expression of 30 stem cell-related TFs in the early and late
passages of DPSC, and found that none of them showed significant changes between these two
passages, suggesting that TFs may not be the key factors causing the loss of differentiation
during long-term culture of DPSC.
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CHAPTER 3: WHOLE TRANSCRIPTOME ANALYSIS OF EARLY AND LATE
PASSAGES OF DENTAL PULP STEM CELLS TO IDENTIFY POTENTIAL GENES
CAUSING LOSS OF DIFFERENTIATION IN LONG-TERM CULTURE
3.1 INTRODUCTION
In Chapter 2, we determined that the differentiation ability of DPSC is reduced as cell
passage increases. Established DPSC at early passages, such as passage 3 and 5 (p3 and p5)
possess strong differentiation capability, but as these cells progress they completely lose that
differentiation ability at passages 9 to 11 (p9 to p11). We conducted experiments to prove that
the loss of differentiation capability was caused by intrinsic changes in DPSC during passaging.
Thus, we analyzed the expression of 30 stem cell-related transcription factors (TFs), but found
that late passage DPSC did not significantly change expression of these TFs when compared to
those in early passages. In order to identify genes causing the loss of differentiation, we decided
to compare the transcriptomes of early and late-passage DPSC. The objectives of this chapter
were (a) to determine what genes were significantly down-regulated in late-passage DPSC when
compared to the early-passage, and (b) to identify candidate genes that might be involved in
regulating differentiation of DPSC. These objectives were accomplished by using whole genome
microarray, real-time RT-PCR, and gene knockdown techniques.
3.2 MATERIALS AND METHODS
3.2.1 Cell Culture
DPSC were established using a published protocol for isolation of dental stem cells [1].
Briefly, dental pulps were isolated from day six rat pups and trypsinized to obtain cell
suspension. For DPSC culture, the cells were grown in α-MEM with 20% fetal bovine serum
(FBS). Cells were then incubated at 37°C and 5% CO2 in humidified incubators. At 90%
confluence, cells were detached using trypsin-EDTA and passaged to a fresh T-75 flask with an
initial density of 200,000 cells per T-75 flask.
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3.2.2 Whole-Genome Microarray Analysis
Whole-genome microarrays provide a powerful tool to study the transcription of the
entire genome, known as the transcriptome, in a given cell population. To compare the
transcriptomes of the early and late passages of DPSC, whole-genome microarray analysis was
employed to obtain the gene transcription profile of p3 and p11 DPSC. For microarray study,
cells were cultured and passaged as described above in Section 3.2.1 until designated passages.
P3 and p11 cells were seeded in T-25 flasks and grown to confluence. Next, cells were collected
and processed for RNA isolation, as described in Section 3.2.5. Concurrently, the cells were
seeded to 6-well plates and subjected to differentiation analysis, as described in Section 3.2.4, to
ensure strong differentiation capability of p3 cells and loss of differentiation of p11 cells.
Microarray analysis was conducted by Phalanx Biotech (Belmont, CA) using a Rat
OneArray containing long oligonucleotides (~60-mer in length) to detect 24,358 transcripts. The
microarray also includes 980 control oligonucleotides for validation and normalization of the
data. Microarray analysis was run in triplicate for each RNA sample. Raw signal intensity of
each transcript was obtained and analyzed. Data was obtained from two sets of DPSC samples.
3.2.3 Analysis of Microarray Data
A generous amount of gene expression data were generated from whole genome
microarray analysis. Proper analysis and data mining was critical. There are two basic types of
data mining methods for whole genome microarray studies, as described by Schulze et al. [2] and
schematically shown in Figure 3.1. Because Method A (Figure 3.1; Section A) was proposed to
answer specific biological questions, and our biological question was to find the gene whose
expression was down-regulated in late-passage DPSC, this method was used for analyzing and
mining the microarray data in this study.
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Figure 3.1 Data mining in whole genome microarray analyses and schematic flowchart to determine the candidate genes in
this study. The method to analyze data from whole-genome microarrays can be classified into two archetypes. (A) Microarray
analysis which compares expression patterns between two experimental samples to address specific questions. (B) Microarray
data from experimental samples are compared to a vast database from collection of other microarrays to discover new gene
pathways and relationships. (C) The flowchart used in this chapter to identify candidate genes involved in loss of
differentiation in DPSC.
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In order to process the large quantities of information obtained from the microarray, we
sought to reduce the overall population of genes to a smaller population by way of establishing
more rigorous criteria for selection of the genes. Our post-microarray analysis followed a similar
pattern described by Schulze et al. [2], and our criteria has been outlined in Figure 3.1. Briefly,
we first compared signal intensity levels between the two separate sets of DPSC samples. We
sought to eliminate those genes that did not display a large decrease in microarray intensity from
early to late passage. After doing so, we used real-time RT-PCR to verify the changes of
expression observed in the microarray data. Next, correlation analysis was conducted to
determine the correlation between differentiation and gene expression. Finally, siRNA was used
to knockdown the expression of selected genes to determine if they possessed the effect to
regulate differentiation of DPSC.
3.2.4 Differentiation of DPSC
Cells were seeded either to sterile 6-well plates at a rate of 5 x 104 cells/well, or to sterile
T-25 flasks at a rate of 1.5 x 105 cells/plate prior to differentiation treatment. Induction medium
was prepared using low glucose DMEM supplemented with 10% FBS, 0.05 mM ascorbic acid,
100 nM dexamethasone, and 10m M β-glycerolphosphate [3]. Cells were incubated in this
induction medium for 14 days prior to staining with Alizarin red S to detect calcium deposition
[4]. Cells were also collected for RNA isolation to analyze gene expression.
3.2.5 RNA Isolation
Cells were collected by trypsinization and pelleted by centrifugation. The pellet was
lysed using 350μL Buffer RLT (Qiagen). Next, RNA was isolated from the lysate using an
automated Qiagen RNeasy DNAse Digest protocol on a Qiacube instrument (Qiagen). Briefly,
70% ethanol was added to the sample at a 1:1 ratio and the mixture was transferred to an RNA-

45

binding spin column. The bound RNA was then washed before incubating in DNAse I reagent
for 15 minutes (Qiagen). The column was washed again, and RNA was eluted with 30 μL
nuclease-free water. After isolation, RNA concentration was measured using a Nanodrop 8000
(Thermo). For microarray analysis, RNA Integrity was measured using an RNA 6000 Nano
LabChip Kit (Agilent Technologies), per the manufacturer’s instructions, using an Agilent 2100
Bioanalyzer. RNA samples that met the following requirements were used for microarray
analysis:
1. Minimum RNA integrity number (RIN) of 8.0
2. OD260/280 > 1.8 and OD260/230 > 1.8
3. Minimum RNA quantity of 6 μg in a concentration greater than 200 ng/μL
3.2.6 Real-Time RT-PCR
Template cDNA was generated from isolated RNA using M-MLV reverse transcriptase
(Invitrogen) with the same methods as described in Chapter 2 (2.2.6). Briefly, 1000-2000 ng
sample RNA was mixed with 250 ng random primer and heated to 65°C for five minutes.
Reverse transcriptase was added, and the reaction was incubated for 50 minutes at 37°C before
deactivation by incubating at 70°C for 15 minutes. The cDNA were stored at -20°C until ready
for analysis. The primer sequences used for PCR are listed in Table 3.1. All reactions were
conducted in 25 μL per reaction containing 1-2 μL cDNA with an ABI 7300 sequence detector
(Applied Biosystems). We used the SYBR real-time PCR to obtain cycle threshold (CT) values
for calculation of relative gene expression (RGE). β-actin was used as control to obtain ΔCT and
ΔΔCT was calculated as described in Chapter 2. RGE was determined using the following
formula:

[5].
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Table 3.1 Real-time PCR primers used in this chapter
Gene
RefSeq
Primers
F: 5’-CTTGGGGAGATCATCAGCAT-3’
Acad9
NM_181768.2
R: 5’-GCAGATACTTGGCCTTCTGC-3’
F: 5’-GATGCCAGAGAAGAGCGAAC-3’
Alx1
NM_012921.1
R: 5’-TAGCTGCAAACTGGTGAACG-3’
F: 5’-GAACCATCCAGGCTCAGAAA-3’
Apbb1ip
NM_001100577.1
R: 5’-CAGCAGCATTTGCTCCATAA-3’
F: 5’-TCGGACTCTGCTGATTGATG-3’
Arhgap20 NM_213629.1
R: 5’-ATTTTGGCCGAGACAAACAG-3’
F: 5’-AGATCGGATGTGGAGAATGG-3’
Clgn
NM_001109472.1
R: 5’-AGGACTCCAGATTCCCTGGT-3’
F: 5’-TTTATCCCCCTTGTGAGACG-3’
Colec11
XM_002729610.1
R: 5’-CCACTGTTTGCTAGCTGCTG-3’
F: 5’-TAAAGCCCTGTGGACCAAAC-3’
Egflam
NM_001108938.2
R: 5’-TCCAGAGCGTGCACTGATAC-3’
F: 5’-TTGGTCACCACCACACAACT-3’
Eya2
NM_130427.1
R: 5’-CAGCTCTCCTTGCCTGTCTT-3’
F: 5’-GGCTTCGCAGACCTCAAGTA-3’
Fam159b XM_574844.3
R: 5’-CAGCAATTCCCAATCCAATC-3’
F: 5’-CACTTGGACTCACCATCACG-3’
Gipc2
NM_001037210.1
R: 5’-ATTCGATATGATCCCCCACA-3’
F: 5’-TCTCCAGAGGGTCTGCTCAT-3’
HspB8
NM_053612.2
R: 5’-GCAGGTGACTTCCTGGTTGT-3’
F: 5’-AGGACGCCTTGAAAAACCTT-3’
PCOLCE2 NM_001127640.1
R: 5’-GCTGGTTCTTCGGAGCTATG-3’
F: 5’-TACGGGGTAGAGACCACAGC-3’
Sial
NM_012587.2
R: 5’-TCGTCGCTTTCCTTCATTTT-3’
F: 5’-TGGATTCGCAAGCTGTGTAG-3’
Slc6a15
NM_172321.1
R: 5’-CCAAGGGAGAGGTTGTTGAA-3’
F: 5’-CTGAGAACCTAGGGCTGCAC-3’
Tcfap2c
NM_201420.2
R: 5’-GGTCCTTTGCGAATGACAGT-3’
F: 5’-TATGACAAGCGAGGGTAGGG-3’
Thbd
NM_031771.2
R: 5’-GGGACACTCTGGGATCTTCA-3’
F: 5’-GGAGGGACCTGTTTTTACCC-3’
Wif1
NM_053738.1
R: 5’-ATGCATTTACCTCCGTTTCG-3’
F: 5’-CGACTCCGGGATCATAACAT-3’
Zfp423
NM_053583.2
R: 5’-TCCGAGAAGAAAGTCCGAGA-3’
3.2.7 Statistical Analyses
Beginning in p3, serial passages of DPSC were grown through p11, and cells were
collected for RNA isolation in early and late passages (i.e. p3, p5, p9, and p11). Potential
candidate genes were selected from the microarray results obtained from the microarray analysis
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described in Section 3.2.3. Relative gene expression (RGE) of those genes was measured using
real-time RT-PCR to compare p3 to p11. Correlation of gene expression and differentiation was
calculated by performing Spearman correlation analysis between the RGE value and
differentiation observed (see Figure 2.5, page 32). SAS program version 9.2 was used for the
correlation analysis.
All other statistical analyses were performed using SAS 9.2 using the GLM ANOVA
procedure. Statistical significance was determined by comparing for least significant difference
(LSD), with p < 0.05 being statistically significant.
3.2.8 Gene Knockdown Experiment
To determine if expression of candidate genes had any effect on differentiation, we used
siRNA-mediated knockdown to reduce the expression of the candidate genes in early-passage
DPSC. We designed and ordered dicer-substrate siRNA (DsiRNA) oligos using the online RNAi
Design Tool, available on Integrated DNA Technologies’s website [6]. A list of the siRNA
sequences used in this experiment can be found in Table 3.2. These siRNA were reconstituted to
a concentration of 100 μM and diluted to a working stock concentration of 10 μM for cell
transfection, as detailed below.
Approximately 30 minutes prior to transfection, all culture medium was aspirated from
the cultures and replaced with 2 mL fresh stem cell media in each flask or well. The
Lipofectamine RNAiMax Transfection reagent (Invitrogen) was used to transfect DPSC with
DsiRNA. Briefly, 9 μL of 10 μM DsiRNA stock was added to 150 μL OptiMEM. Concurrently,
9 μL of RNAiMax reagent was added to a separate 150 μL volume of OptiMEM. The two
solutions were then mixed at a 1:1 ratio and incubated at room temperature for five minutes to
form the lipofection complex. Immediately following incubation, 250 μL of the appropriate
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Table 3.2 Sequences used for DsiRNA transfection
Gene
RefSeq
Sequence*
Antisense: 5'-rGrUrCrCrUrArUrUrUrCrArArArUrGrCrCrUrUr
CrUrUrGrGrGrUrU-3'
Gipc2 NM_001037210.1
Sense: 5'-rCrCrCrArArGrArArGrGrCrArUrUrUrGrArArArUr
ArGrGAC-3'
Antisense: 5'-rGrGrArGrArCrArArUrCrCrCrArCrCrUrUrCrUr
UrGrCrUrGrCrUrU-3'
HspB8 NM_053612.2
Sense: 5'-rGrCrArGrCrArArGrArArGrGrUrGrGrGrArUrUrGr
UrCrUCC-3'
*The sequences listed are RNA sequences, with “r” indicating the ribose in between
nucleotides.
complex was added to each flask or well, and the cells were incubated at 37°C for 24 hours.
After incubation, the medium containing the lipofection complex was removed and fresh stem
cell culture medium was added. Cells were cultured normally after this.
To determine knockdown efficiency, cells were collected every four days until day 13
post-transfection for total mRNA isolation. We then used real-time PCR to determine the relative
expression levels of these genes (RGE) when compared to a transfection control concurrently
with each treatment groups. The primers for real-time PCR are listed in Table 3.1.
To determine if knockdown of the candidate genes decreases differentiation ability of
DPSC, differentiation induction medium was added to the cells 48 hours after initiating
transfection. The induction medium was prepared using low glucose DMEM supplemented with
10% FBS, 0.05 mM ascorbic acid, 100 nM dexamethasone, and 10 mM β-glycerolphosphate [3].
Cells were incubated in induction medium for 14 days prior to staining with alizarin red S [4].
3.3 RESULTS
3.3.1 Comparison of the Transcriptomes of Early and Late Passages of DPSC
There were 76 genes showing at least a two-fold differential expression in p3 and p11
DPSC. Of the 76 genes, 34 genes had decreased their expression more than 10-fold in p11, as
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compared to p3. The detailed fold-differential expression of these genes from microarray
analysis can be found in Table 3.3. We selected 18 genes from these 34 genes, based on their
displaying increased expression in p3 consistent in both microarray data sets, for further analysis
using real-time RT-PCR with primers listed in Table 3.1. A list of these 18 genes and their fold
changes in the microarray analysis can be found in Table 3.4.
Table 3.3 Microarray genes with greater than 10-fold change in intensity
Change in Intensity
Gene
> 100 fold
Egflam
100 fold – 50 fold
Acad9, Thbd
50 fold – 30 fold
Colec11, Myh11, Sial, Slc6a15, Tmem117
30 fold – 15 fold
Alx1, Ccdc64, Cyp27a1, Eya2, Fam159b, Hspb8, Tc2n, Tcfap2c,
Wif1, Zfp423
15 fold – 10 fold
Abcg2, Apbb1ip, Arhgap20, Cdh10, Clgn, Cyp2j3, Fgf12, Gipc2,
Khdrbs3, LOC100360067, Msx2, Olr377, PCOLCE2, Pls1, Reln, Slpi
3.3.2 Confirmation of Expression of Selected Genes with RT-PCR
Real-time RT-PCR was conducted to determine the expression of the 18 genes in p3 and
p11 DPSC. Relative gene expression (RGE) was calculated from the CT values by normalizing to
p3 as a control, with RGE of 1. RGE values less than 1.0 indicated decreased expression when
compared to p3. While Acad9 displayed an upward trend that contradicted the microarray data
(Figure 3.2), most of the selected genes reduced their expression as cell passages increased to
p11, however, some of them were not statistically significant (Figure 3.2). The following 13
genes displayed significant reduction in expression in p11 when compared to p3: Apbb1ip, Clgn,
Colec11, Eya2, Fam159b, Gipc2, HspB8, Pcolce2, Slc6a15, Tcfap2c, Thbd, Wif1, and Zfp423
(Figure 3.2). These genes were selected for correlation analysis to determine the correlation
between differentiation and expression of those genes in different passages.

50

Table 3.4 Genes identified from microarray and selected for real-time RT-PCR analysis and
their fold-change in signal intensity comparing p3 to p11 in two sets of RNA samples
Gene
RefSeq
Known Function
Fold Change
Fold Change
(p3/p11 Set 1) (p3/p11 Set 2)
Acad9
NM_181768.2
Mitochondiral protein
associated with fatty acid 74.4
34.6
digestion
Alx1
NM_012921.1
Alias "CART1,"
embryonic gene expressed
21.7
13.4
in craniofacial
development
Apbb1ip
NM_001100577.1 Alias "RIAM," Interacts
with Rap1-GTP, promotes
13.9
54.0
integrin-mediated
adhesion
Arhgap20 NM_213629.1
Inactivates Rho protein,
12.8
10.4
causing neurite outgrowth
Clgn
NM_001109472.1 Molecular chaperone
protein, primarily
14.3
23.2
associated with
spermatogenesis
Colec11
XM_002729610.1 Strongly expressed
embryonically in
craniofacial cartilage,
35.5
313.5
heart, kidney, & vertebral
bodies
Egflam
NM_001108938.2 Alias "Pikachurin," ECM
protein associated with
134.9
10.5
photoreceptor synapse
formation
Eya2
NM_130427.1
Transcriptional
coactivator, regulates
19.1
88.1
physiological hypertrophy
Fam159b XM_574844.3
Sequence with unknown
18.9
25.4
function
Gipc2
NM_001037210.1 Associates with TGF-β
receptors, Wnt pathway
12.8
12.1
messenger
HspB8
NM_053612.2
Alias "Hsp22," Small
heat-shock protein family
member, expressed in
17.7
6.2
motor neurons & cardiac
tissue
PCOLCE2 NM_001127640.1 Binds to BMP1 to
enhance the lysis of
13.7
10.9
Proapolipoprotein
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(Table 3.4 continued)
Gene
RefSeq
Sial

NM_012587.2

Slc6a15

Tcfap2c

Thbd

NM_172321.1

NM_201420.2

NM_031771.2

Wif1

NM_053738.1

Zfp423

NM_053583.2

Known Function
Alias "Ibsp," Encodes
BSP, Osteogenic marker,
ECM protein which
Neuronal transporter
protein, used to transport
amino acids
Embryonic stem cell gene,
expressed primarily in
germ cells
Transmembrane protein in
endothelial cells, binds to
Thrombin to regulate
coagulation
Extracellular protein that
binds to Wnt and inhibits
its effects
Expressed in preadipocyte
stromal tissue prior to
adipogenesis

Fold Change
(p3/p11 Set 1)

Fold Change
(p3/p11 Set 2)

35.3

8.0

47.4

9.4

26.7

8.1

83.7

81.5

18.1

19.8

16.1

6.6

3.3.3 Correlation of Gene Expression and Differentiation
We conducted Spearman correlation analysis to determine any correlation between
expression of the selected genes and differentiation capability in different passages of DPSC.
The results of this correlation analysis are listed in Table 3.5. The individual RGE of each gene,
as well as the non-parametric differentiation scores for different passages (p3, p5, p9 and p11),
can be found in the Appendix. The correlation analysis showed that Gipc2 has the maximal
correlation with a correlation coefficient of 0.86, followed by Apbb1ip and Fam159b with
correlation coefficients of 0.82. The correlation coefficients of other genes were below 0.80
(Table 3.5).
3.3.4 Gene Knockdown Study
Two genes (Gipc2 and HspB8) were selected for knockdown experiments. Gipc2 was
selected because it had the maximal correlation between its expression and differentiation in
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Figure 3.2 Real-time RT-PCR to confirm expression of genes selected from microarray
analysis. Comparison of RGE in p3 and p11 DPSC for the genes selected from the initial
microarray results. (* indicates statistical significance, p < 0.05; n=3). p11 was
normalized to p3 which was set as 1.
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(Figure 3.2 continued)
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Table 3.5 Correlation analysis of differentiation with relative gene expression in different
passages of DPSC
Gene
Correlation coefficient
Apbb1ip
0.81989
Clgn
0.76087
Colec11
0.26998
Eya2
0.74080
Fam159b
0.81989
Gipc2
0.85904
HspB8
0.46634
Pcolce2
0.69141
Slc6a15
0.41725
Tcfap2c
0.46634
Thbd
0.72957
Wif1
0.46634
Zfp423
0.26998
different passages. HspB8 was of interest because dental stem cells appeared to be more thermal
tolerant than their non-stem cell counterparts, and we have reported that dental stem cells also
expressed higher level of some heat shock proteins than their non-stem cell counterpart [6, 7].
Because 14 days of induction is required for in vitro differentiation of DPSC, we
conducted a time-course study to check the gene knockdown efficiency. As shown in Figure 3.3,
the post-siRNA transfection knockdown effects appear to last through day 13 for both genes
tested. The maximum knockdown appeared to be over 90% for up to nine days post-siRNA
transfection for both Gipc2 and HspB8 (Figure 3.3; Section A). A knockdown efficiency of 65 to
80% was still achieved at day 13, which was statistically significant (Figure 3.3; Section B).
3.3.5 Effect of Gene Knockdown on Differentiation of DPSC
With successful knockdown of gene expression following transfection of early-passage
DPSC with siRNA, we tested whether knockdown of the genes would alter differentiation
capability. In this experiment, siRNA transfected DPSC were subjected to differentiation
induction for 14 days. Alizarin red staining showed that knockdown of HspB8 resulted in a
55

Figure 3.3 Knockdown efficiency of Gipc2 and HspB8 expression by siRNA. (A) DPSC
were transfected with the appropriate siRNA and cells were collected every four days to
determine knockdown efficiency using real-time RT-PCR. siRNA transfected cells displayed
a sustained knockdown of Gipc2 or HspB8 through 13 days post-transfection. (B) An average
of greater than 65% knockdown was still observed at day 13 after transfection, which was
statistically significant.
significant reduction of calcium deposition. In fact, in some replicates, almost no calcium
deposition was observed when HspB8 expression was inhibited, as shown in Figure 3.4. In
contrast, knockdown of Gipc2 appeared to have no effect on calcium deposition, as compared to
the transfection control. This experiment suggested that HspB8 may play a vital role in
maintaining differentiation capability of DPSC.
3.4 DISCUSSION
With whole genome DNA microarray, we screened 24,358 transcripts in early-passage
and late-passage DPSC. Huge amounts of data were generated from the two sets of DPSC
samples. We used the method described by Schulze et al [2] to address our question of mining
for candidate genes in causing loss of differentiation during in vitro expansion of DPSC.
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A

B

C

Figure 3.4 Differentiation of early-passage DPSC after knockdown of the expression of
HspB8 and GipC2 as determined by Alizarin red staining. (A) Alizarin red positive calcium
deposition shown in the control. (B) Little or no change in calcium deposition was seen in
DPSC after knockdown of Gipc2 expression. (C) Knockdown of HspB8 resulted in dramatic
reduction of calcium deposition.
Other investigators have found large variability of microarray data [2]. Because of the
high variability in microarray analysis, using other techniques such as RT-PCR to verify the
microarray results is very important. However, it is unfeasible to verify such large numbers of
genes. Thus, selection of genes for RT-PCR verification was necessary. Based on our microarray
data, we selected 18 genes whose signal intensity in p3 was 10-fold greater than in p11 for RTPCR analysis.
With real-time RT-PCR, we obtained the CT values of these 18 genes in p3 and p11 of
DPSC. From the CT values, we calculated the RGE of the genes to compare gene expression
(Figure 3.2). Genes with no significant difference in RGE between p3 vs. p11 were eliminated.
These selection procedures allowed us to narrow down to 13 genes for further study.
Finally, we conducted correlation analysis to determine the correlation between gene
expression and differentiation potential in different passages of p3, p5, p9 and p 11 DPSC. We
selected Gipc2 and HspB8 for gene knockdown study. Expression of Gipc2 showed maximal
correlation to reduction of differentiation in different passages, and expression of HspB8 had a
moderate correlation with differentiation across passages. Surprisingly, knockdown of Gipc2 did
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not show any effect on differentiation (Figure 3.4); however, knockdown of HspB8 did result in
dramatic reduction of differentiation.
Gipc2 is a homologue to the first member of its respective gene family, GIPC1 [8], which
was first discovered in 1999 to associate with the cytoplasmic domain of the axon neural protein
M-SemF [9]. Little is currently known about GIPC2, but its expression has been tied to a number
of different forms of gastric cancer [10]. However, when it was discovered, GIPC2 was found to
associate with TGF-β receptors or other types of Wnt receptors [8]. Takeda et al. discovered a
drastic change in the expression of Wnt16 through serial passaging of DPSC [11], and the strong
correlation of GIPC2 expression to differentiation hints at a potential relationship between the
two genes and differentiation. In this study, we showed that knockdown of Gipc2 had no effect
on differentiation of early passage DPSC, suggesting that it may not be involved in regulation of
differentiation.
Heat shock proteins (Hsps) have been found to play vital roles in regulating many aspects
of stem cells, including self-renewal, differentiation, dormancy, and senescence of stem cells
[12]. In addition, our lab had also recently shown that DFSC express higher levels of some Hsps,
including small heat shock proteins (HspB1 and HspB2) than their non-stem counterparts [7].
HspB1, also known as Hsp27, has been shown to interact with HspB8 to regulate cell fate [13].
In addition, we had also previously found that DFSC increase their proliferation and
differentiation under proper heat stress [14]. HspB8 is also a small heat-shock protein that is
required for proper neurite formation in motor neurons [15, 16]. It has also been found to exhibit
chaperone-like qualities both in cardiac tissue [17] and during in vitro culture [18]. When we
consider that DPSC arise from the neural crest [19], as well as possess the capability to
differentiate into neural tissue in vitro [20], the potential relationship between HspB8 and DPSC
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seems more likely. Our gene knockdown study showed that knockdown of HspB8 expression
indeed resulted in abolishment of differentiation in early-passage DPSC, suggesting that HspB8
may exert a function in differentiation of DPSC, which is a novel finding regarding the role of
HspB8. Thus, it was our deep interest to further study the gene expression regulation of this
small heat shock protein in DPSC.
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CHAPTER 4: CONSTRUCTION OF HEAT SHOCK PROTEIN B8 (HSPB8)
EXPRESSION VECTORS AND EXPLORING THE REGULATORY MECHANISM OF
HSPB8 EXPRESSION IN DPSC
4.1 INTRODUCTION
It is well known that heat shock proteins (Hsps) are molecular chaperones that can
function to stabilize intracellular proteins and repair damaged proteins under stress conditions.
We observed that dental follicle stem cells express higher levels of some Hsps than the non-stem
dental follicle cells originating from the same tissue [1]. It is likely that Hsps are required to
stabilize factors for maintaining the “stemness” of ASC under in vitro condition. Although Hsps
are classically considered as cell stress defense proteins, they are also involved in gene
expression regulation [2]. Hsps were found to play vital roles in regulating many aspects of stem
cells, including self-renewal, differentiation, dormancy, and senescence of stem cells [3].
HspB8, also known as Hsp22, belongs to the Small Heat Shock Protein family and is
known for its role in pleiotropic prosurvival effects in cells. There is limited information
regarding the role of HspB8 in stem cell behavior or properties. One study indicated that
expression of HspB8 was increased during neuron differentiation in vitro, and overexpression of
HspB8 promoted neuron differentiation [4]. The role of HspB8 in maintaining differentiation
potential of stem cells and its regulation in stem cells are largely unknown.
In the previous chapter, we found that expression of HspB8 was significantly and
dramatically down-regulated in late-passage DPSC (p11), which have lost differentiation
capability. Furthermore, knockdown of HspB8 expression in early-passage DPSC caused the
cells to lose their differentiation ability. Thus, HspB8 appears to be an important gene (or one of
the important genes) to maintain differentiation in DPSC. In this chapter, we attempted to clone
the HspB8 cDNA into a plasmid to construct HspB8 overexpression vectors. The purpose of
constructing the HspB8 expression vectors is two-fold. First, with the expression vectors, we
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could force the late passage DPSC to overexpress HspB8 by transfecting the vectors into the
cells. Such an overexpression study would allow us to assess if HspB8 can function
independently to regulate differentiation, or if it depends on other factors to exert the regulatory
role. Secondly, because microRNAs (miRNAs) have been shown to play an essential role in stem
cell self-renewal and differentiation [5-9], and because miRNAs are believed to regulate a large
percentage of genes in mammalian cells [10], the constructed vectors could be used to explore if
miRNAs are involved in regulating the expression of HspB8. This chapter provided strong
evidence to show the possibility of miRNAs in regulating HspB8 expression.
4.2 MATERIALS AND METHODS
4.2.1 Cell Culture
DPSC were established using a published protocol for isolation of dental stem cells [11].
Briefly, dental pulps were isolated from rat first mandibular molars and trypsinized to obtain cell
suspension. For DPSC culture, the cells were grown in α-MEM with 20% fetal bovine serum
(FBS). Cells were then incubated at 37°C and 5% CO2 in humidified incubators. At 90%
confluence, cells were detached using trypsin-EDTA and passaged to a fresh T-75 flask with an
initial density of 200,000 cells per T-75 flask.
In preparation for experimentation, cells were either seeded to T-25 flasks or 6-well
plates. For experiments that required assaying of total protein, we seeded 1.5 x 105 cells to each
T-25 flask. Cells destined for assaying by Alizarin red staining or collection of total mRNA were
seeded to 6-well plates at 5.0 x 104 cells per well.
4.2.2 Clone HspB8 cDNA Fragments
To clone HspB8 cDNA, 2 μg RNA extracted from DPSC was reverse-transcribed into
cDNA using Oligo-dT primers to synthesize cDNA of the full mRNA transcript. A pair of PCR
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primers (forward 5'-GCACGAATTCCAACAAACACCATGGCTGAC-3' and reverse 5'GCACAAGCTTGGAAGGTCCCCAGAGAAAAG-3') was designed to amplify the HspB8
cDNA sequence. This sequence contains the 590bp coding DNA sequence (CDS) and a 383bp 3’
untranslated region (3’UTR). PCR was conducted by mixing cDNA and the primers, and run for
35 cycles. The PCR product was electrophoresed and HspB8 cDNA was purified with a gel
extraction kit (Qiagen). This DNA fragment contained restriction enzyme sites of EcoRI
(GAATTC) and HindIII (AAGCTT) on the ends. With the same procedures, we also cloned the
CDS only region using another primer pair (forward 5’-CTGAATTCATGGCTGACGGGCAAT
TGCCT-3’ and reverse 5’-CGAAGCTTTTAGGAGCAGGTGACTTCCTGGT-3’).
4.2.3 Construction of the HspB8 Expression Vectors
Each of the cDNA fragments was inserted into the multiple cloning site (MCS) of
expression vector pCMV-3Tag-3 (Figure 4.1), such that the transcription of the fragments is
driven by the CMV promoter using the procedures detailed below. We first digested the HspB8
DNA fragment and the plasmid separately with EcoRI and HindIII (New England Biolabs) at
37°C for one hour, followed by enzyme deactivation at 65°C for 20 minutes. To prevent autoligation, the digested plasmid and DNA fragment were subjected to agarose gel electrophoresis,
followed by gel extraction and purification using the Qiaquick Gel Extraction Kit (Qiagen) to
collect the linear plasmid and HspB8 DNA fragment with sticky ends. Next, the linear plasmid
and DNA fragment were mixed in a ligation reaction at a ratio of 0.09 pmol:0.03 pmol with the
presence of T4 DNA ligase (New England Biolabs). Ligation was performed by incubating the
mixture at 16°C overnight.
Following ligation, the mixture was used to transform competent E. coli cells. Briefly,
competent E. coli cells (New England Biolabs) were thawed on ice for 30 minutes. After adding
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Figure 4.1 Illustration of the Cloning of HspB8 cDNA CDS+3’UTR into expression
vector pCMV-3Tag-3. Rat HspB8 cDNA was amplified using primers that contained
hanging restriction sites for EcoRI and HindIII. The PCR product and the plasmid vector
were digested with EcoRI and HindIII. The cDNA fragment was inserted into the
vector.
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the mixture to the E. coli, the bacteria were incubated for 30 minutes on ice, followed by heatshock at 42°C for 30 seconds. The competent E. coli were then incubated on ice for five minutes
before suspension in SOC medium (New England Biolabs) and incubated on a shaker at 37°C for
one hour. Finally, the transformed E. coli were spread to a LB medium plate containing
kanamycin as a selection drug and incubated overnight at 37° C for formation of bacterial clones.
The plasmids containing putative HspB8 insertion were isolated from the clones using the
QIAPrep Spin Miniprep Kit (Qiagen).
To confirm that the plasmids contained the correct HspB8 insertion, the newly
constructed plasmid, along with the original pCMV-3Tag-3 plasmid, were digested with EcoRI
and/or HindIII for fiv0065 hours. Immediately after digestion, aliquots were separated via
agarose gel electrophoresis to identify the correct DNA fragment bands.
The new plasmids that displayed the correct plasmid+insertion pattern were sent to LSU
GeneLab for sequencing with T3-19 primer (5’-CAATTAACCCTCACTAAAG-3’) and T7-19
primer (5’-GTAATACGACTCACTATAG-3’). The sequence received from GeneLab was
analyzed using UGENE [12]. The sequence was aligned in BLAST with the RefSeq of rat HspB8
(NM_053612.2) published in the Gene Bank.
4.2.4 Transfection of DPSC with Gene Expression Vectors
DPSC were grown to 80% confluence. One hour prior to transfection, culture medium
was removed, and fresh medium was added to the cultures. DPSC were transfected using the
PolyJet™ DNA In Vitro Transfection Reagent (Signagen), a biodegradable polymer DNA
transfection reagent, according to the manufacturer’s protocol. Briefly, plasmids were diluted in
serum-free high glucose DMEM medium (Invitrogen). Concurrently, PolyJet™ reagent was
added to a separate volume of DMEM. Then, the plasmid solution and PolyJet™ solution were
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mixed in a 1:1 volume ratio and incubated at room temperature for 15 minutes. The combined
mixture was then added drop-wise to the cells in culture at 0.1 mL mixture to 1 mL medium. The
cells were incubated for 24 hours. Next, the medium containing transfection reagent was
removed and replaced with fresh culture medium. This general transfection protocol was applied
to the following two transfection experiments.
We first optimized the protocol for transfection of DPSC using the pCMV-βLac-Zco
plasmid (Marker Gene Technologies), which contains the LacZ reporter gene. To do this, we
seeded 2.5 x 104 DPSC to each well of a 12-well plate. When cells reached 80% confluence, they
were transfected with pCMV-βLac-Zco at the final concentrations of 0.1, 0.2, 0.5, 1.0, or 1.5
μg/mL using the above mentioned PolyJet™ protocol. After 24 hours, the transfection medium
was removed and fresh culture medium was added to the cells. After an additional two days of
incubation, cells were fixed and stained using X-Gal staining to determine the transfection
efficiency. Briefly, cells were rinsed with PBS and fixed in 10% formalin for five minutes, and
washed again with PBS. The fixed cells were incubated with X-Gal staining solution at 37°C
overnight. Cells were then rinsed once with PBS, followed by rinsing in 100% ethanol for 10-30
minutes. After aspirating the ethanol, the fixed cells were counterstained with eosin Y for 30
seconds, followed by a rinse with 95% ethanol for one minute and three rinses in 100% ethanol
for one minute each. The stained plates were then photographed under a microscope. The
number of blue transfected cells and total cells in a given area were counted. Transfection
efficiency was calculated as the percentage of the transfected cells to total cells.
Using the optimized protocol, we transfected DPSC with the HspB8 expression vectors.
Following transfection at designated times, cells were harvested in Buffer RLT for total RNA
extraction using RNeasy mini kit (Qiagen) or harvested into Cytobuster buffer for extraction of
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total protein. The RNA samples were treated twice with Turbo DNase I (Ambion) to ensure
complete removal of the possible plasmid contamination. Next, 1-2μg RNA was reversetranscribed into cDNA, followed by PCR to determine the overexpression of HspB8 and other
genes, as listed in Table 4.1. In addition, Western blotting was conducted to analyze the protein
samples to determine the translation of HspB8, as detailed below.
4.2.5 Western Blotting
DPSC were harvested and lysed in Cytobuster Protein Extraction Reagent (Millipore) to
obtain total protein. Protein was quantified by Pierce BCA assay. Then, equal amounts of the
total protein were subjected to Western blotting analysis. Briefly, 15-25 μg of protein from each
sample was diluted to 20 μL and mixed with 4 μL of 6X-stock loading buffer consisting of 60%
glycerol, 12% sodium dodecyl sulfate (SDS), 0.3M dithiothreitol (DTT), 0.375M Tris (pH 6.8),
and 0.06% bromophenol blue. The sample mix was denatured in a 95-100°C water bath for five
minutes before being loaded into a 5% polyacrylaminde stacking gel. polyacrylamide gel
electrophoresis (PAGE) was conducted at 80V for 15 minutes, followed by separation at 130V
for 60-80 minutes. Then, the gel was immediately removed and proteins were transferred to a 0.2
μm Immuno-Blot PVDF membrane (Bio-Rad) by electrophoresis at 100 – 110V for 60 – 100
minutes.
The membranes bound with protein were blocked for one hour at room temperature in
0.05% Tween-20 in PBS (PBST) with 5% blotto dry milk (Santa Cruz Biotechnology).
Following blocking, samples were incubated with 0.5-2.0 μg/mL primary antibodies in 2%
bovine serum albumin (BSA, Amresco) PBST at 4°C overnight. Following primary antibody
incubation, membranes were washed five times in PBST at room temperature for five minutes
before incubating with secondary antibody. All secondary antibodies were diluted in PBST
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Table 4.1 Primers used for real-time RT-PCR
Gene
RefSeq
Primer Sequence
Forward: 5'-CTAAGGCCAACCGTGAAAAGAT-3'
Actin
NM_031144.3
Reverse: 5'-AGAGGCATACAGGGACAACACA-3'
Forward: 5'-TCTCCAGAGGGTCTGCTCAT-3'
HspB8 NM_053612.2
Reverse: 5'-GCAGGTGACTTCCTGGTTGT-3'
*RunX2 mRNA has two separate isoforms, with isoform 2 having a shorter 5' untranslated
region and CDS region, as well as the translated protein having slightly different N-terminus
and being shorter than isoform 1. The primers listed flank a sequence conserved between the
two isoforms.
containing 2% BSA, and membranes were incubated with secondary antibodies for 1 – 2 hours at
room temperature. Following secondary antibody incubation, the membranes were once again
washed five times in PBST. The membranes were then stained using SuperSignal West Dura
Extended Duration Substrate (Thermo Scientific) for 2-5 minutes to develop protein signals, and
the signals were captured using a Chemidoc XRS. Image processing was performed using
Quantity One 1-D Analysis Software (Bio-Rad).
4.3 RESULTS
4.3.1 Construction of HspB8 Expression Plasmid Vector
E. coli clones containing putative HspB8 expression plasmids were picked for plasmid
isolation. Enzymatic digestion and gel electrophoresis indicated the insertion of the correct DNA
fragment of HspB8 CDS or HspB8 CDS + 3’UTR into the EcoRI and HindIII sites of pCMV-3Tag-3, as shown in Figure 4.2. The plasmids were sent to LSU Genelab for sequencing. The
resultant sequences were aligned with the NCBI Genebank HspB8 mRNA sequence, and the
result showed a perfect match in the CDS, with only one mismatch occurring in the 3’
untranslated region (3’UTR) in the plasmid containing CDS+3’UTR, which is believed to be a
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Figure 4.2 Enzymatic digestion of putative plasmid constructs to determine the correct
insertion of HspB8 cDNA into pCMV-3Tag-3 plasmid. (A) Example for screening E. coli
clones containing putative HspB8 CDS+3’UTR insertion by enzymatic digestion. Digestion
of putative plasmid containing HspB8 CDS and 3’UTR (pCMV-3Tag3-HspB8CDS-3’UTR)
yielded correct pattern with the correct DNA fragment insertion indicated by arrows in clones
2 and 3. Note that expected fragment was absent in Clone 1, indicating improper ligation of
the plasmid, and this clone was discarded. (B) Showing that enzymatic digestion of pCMV3Tag3-HspB8CDS-3’UTR and pCMV-3Tag3-HspB8CDS resulted in correct pattern and
insertion of HspB8 CDS +3’UTR and HspB8 CDS (arrows) into the plasmids. Key: L – DNA
ladder marker; E – sample digested with EcoRI; E+H – sample digested with EcoRI and
HindIII
single- nucleotide polymorphism (SNP). These plasmids were respectively named pCMV3Tag3-HspB8CDS and pCMV-3Tag3-HspB8CDS-3’UTR, , and the E. coli clones harboring
these plasmids were saved for propagation of the HspB8 expression vectors.
4.3.2 Optimization of DPSC Transfection
We optimized the PolyJet™ protocol for transfection of DPSC using the Lac-Z reporter
plasmid. We found that PolyJet™ could be used to effectively transfect DPSC (Figure 4.3). The
optimal transfection efficiency was seen at plasmid concentrations ranging between 0.5 μg/mL
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and 1 μg/mL. Averagely, 50% to 60% of cells were transfected at this condition. Greater than
80% cells were transfected in some areas (Figure 4.3).
4.3.3 Transfection of HspB8 Expression Vectors into DPSC
When pCMV-3Tag3-HspB8CDS-3UTR and pCMV-3Tag-CDS were transfected into
early and late-passages of DPSC, RT-PCR showed that both passages of DPSC exhibited a
strong increase in HspB8 mRNA expression within 24 hours after transfection with both
plasmids, as compared to the control transfection with pCMV-3tag3 (Figure 4.4; Sections A and
B).
Protein was collected from the transfected cells for Western blotting analysis to determine the
translation of mRNA. Interestingly, increased HspB8 protein expression was seen in the earlypassage DPSC transfected with both plasmids; however, in late passage DPSC, a dramatic
increase of protein expression was only seen in the cells transfected with the plasmids containing
HspB8 CDS (Figure 4.4; Section C), but not in the cells transfected with the vector containing
CDS+3’UTR (Figure 4.4; Section D). Because the 3’UTR is the major target site for miRNAs,
this result indicated that miRNAs play an important role in regulation of HspB8 expression in
DPSC. Specifically, reduced expression of HspB8 expression seen in late-passage DPSC was
due to high level expression of certain miRNAs.
4.4 DISCUSSION
DPSC lose their differentiation capability alongside decreasing expression of certain
genes in late passages. We have previously determined that expression of Gipc2 and HspB8 was
greatly and significantly reduced in late passage DPSC, where DPSC lose their differentiation
ability. The expression of these genes in later passages could be reduced on average by 70% or
more when compared to the early passages. We had also previously confirmed that knockdown
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NT – 0%

Ctrl – 0%

0.1 μg/mL – 4.8±3.5%

0.2 μg/mL – 25.0±6.7%

0.5 μg/mL – 55.3±14.3%

1.0 μg/mL – 55.2±7.1%

1.5 μg/mL – 41.4±13.5%

Figure 4.3 Optimization of DPSC Transfection using PolyJet™ DNA In Vitro Transfection
Reagent. Different concentrations of pCMV-βLac-Zco plasmid were transfected into DPSC
with PolyJet™ protocol. X-Gal staining showed that optimal plasmid concentration was
between 0.5 to 1.0μg/mL with 55% cells transfected. (mean+SD, n=6) Key: (NT) nontransfected cells, (Ctrl) cells transfected without LacZ. All images are 50x magnification.
of HspB8 caused loss of differentiation in early-passage DPSC, but knockdown of Gipc2 did not
have an effect. We therefore speculate that HspB8 is involved in maintaining differentiation
capability of DPSC.
To further study HspB8, we cloned the different fragments of HspB8 cDNA into an
expression vector. In late-passage DPSC, transfection of the vector expressing HspB8 CDS+
3’UTR resulted in an increase in transcription of the genes into mRNA, but translation of the
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Figure 4.4 Transfection of plasmid vector to overexpress HspB8 CDS+3UTR or CDS
constructs in p5 and p11 DPSC. Note that the increase in HspB8 mRNA were seen in both
CDS+3’UTR and CDS transfections in both p5 (A) and p11 DPSC (B) shown by RT-PCR.
Dramatic increase of protein expression was seen in p5 DPSC transfected with both plasmids
(C). In contrast, for p11 DPSC, a dramatic increase of protein expression was seen in CDS
transfection, but not in CDS+3’UTR transfection (D) as determined by Western blot. Instead,
only slight increase of HspB8 protein was seen in CDS+3’UTR transfection (D).
mRNA was inhibited. However, transfection of CDS to the same cells resulted in
overexpression of both mRNA and protein (Figure 4.4; Sections B and D). Thus, the presence of
the 3’UTR apparently blocked the translation of mRNA in a posttranscriptional manner.
Recent studies revealed that miRNAs are important posttranscriptional regulators [6].
The main function of miRNAs is to downregulate gene expression by several mechanisms,
including translational repression, mRNA cleavage, and mRNA deadenylation/destabilization
[13]. After examining thousands of protein genes in response to miRNAs, Baek et. al. concluded
that the target sites for most miRNA are located in the 3’UTR of mRNA transcripts in animal
cells [14]. Given the facts about miRNAs, the above overexpression experiment provides strong
evidence that miRNAs play an important role in regulating HspB8 expression.
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Moreover, transfection of early passage of DPSC with the aforementioned HspB8
expression vectors increased expression of mRNA and protein regardless of the presence or
absence of the 3’UTR (Figure 4.4; Sections A and C). We speculate that this was because the
early passage DPSC had nonexistent or low levels of HspB8-targeting miRNAs. As cell passages
progressed, DPSC increased expression of HspB8-targeting miRNAs, and as a result a decrease
in the expression of HspB8 was seen in the p11 DPSC.
In an experiment attempting to restore differentiation capability of late passage DPSC by
overexpression of HspB8, we did not observe a positive effect (data not shown). We reasoned
that it is likely that HspB8 cannot independently reverse the process, and that other downregulated genes or factors are also involved in maintaining the differentiation potential of DPSC.
Further studies are needed to elucidate those genes.
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CHAPTER 5: CONCLUDING REMARKS
5.1 OVERALL SUMMARY OF FINDINGS
As discussed in Chapter 1, use of ASC for tissue regeneration prevents some problems
associated with ESC [1]. On the other hand, the use of ASC requires the constant re-isolation of
primary cultures, since in vitro culture of ASC reduces their differentiation capabilities over time
[2, 3]. For stem cells, such as dental pulp derived stem cells (DPSC), this challenge is further
magnified due to the low volume and availability of the tissue source. However, DPSC possess
the ability to differentiate into a variety of different tissues, such as adipogenic, chondrogenic,
and myogenic tissues [4, 5]. Therefore, any discovery that preserves their differentiation
capability during in vitro culture would further enhance their utility.
In Chapter 2, we examined the capability of DPSC to differentiate into one of its many
potential cell types: the calcium-depositing cells. This ability has been shown to persist in vitro
for DPSC cultures as late as p9 [3]. We showed that calcium depositing cells derived from DPSC
might contain osteoblasts, odontoblasts, and ameloblasts. While serial passaging of DPSC
resulted in a change in cell morphology, the cells also eventually lost differentiation potential
around p11. However, these cells remained distinct from non-stem dental pulp cells (DPC). In
particular, a number of stem cell marker genes, such as KitL [6] and Esrrb [7], continued to be
strongly expressed in the late passage DPSC when compared to DPC. We screened a number of
different stem cell-related transcription factors, but none significantly changed/reduced its
expression in the late passage DPSC.
The scope of our study expanded in Chapter 3, and we conducted a whole-genome
microarray analysis to search for as many potential differences between early and late-passage
DPSC as possible. From there, we found 18 genes with a marked decrease in expression in late-
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passage DPSC. After confirming the decrease in expression in most of these genes by real-time
RT-PCR, we selected two genes, Gipc2 and HspB8, for further study. Using shRNAi, we
knocked down the expression of these candidate genes in early-passage DPSC and attempted to
induce differentiation. When knockdown of HspB8 almost completely prevented differentiation
in early-passage DPSC, we concluded that high level expression of HspB8 is important for
DPSC to maintain differentiation potential.
In Chapter 4, with evidence that HspB8 expression is important in differentiation, we
sought to clone the cDNA of HspB8 into plasmid vectors that would constitutively overexpress
HspB8 when transfected into DPSC. We cloned two DNA fragments from HspB8 cDNA, and
inserted them into pCMV-3Tag-3 (Agilent) to construct Hspb8 expression vectors. Fragment 1
contained HspB8 coding sequence (CDS) and 3’untranslated region (3’UTR), and fragment 2
contained only HspB8 CDS. These vectors were transfected into p5 and p11 DPSC using the
optimized PolyJet™ protocol. Transfection of the vector containing both the HspB8 CDS and
3’UTR increased HspB8 mRNA in both early and late passages of DPSC, but the increase of
HspB8 protein was only seen in early-passage DPSCs. In contrast, transfection of the vector
containing only the HspB8 CDS (lacking the 3’UTR) resulted in a dramatic increase of HspB8
mRNA and protein for both early and late passages of DPSCs. Given that the 3’UTR is the
major target site for miRNAs, the results strongly suggest that miRNAs are responsible in posttranscriptional regulation to downregulate HspB8 in late-passage DPSCs. This was one of the
most important findings of this research.
5.2 SIGNIFICANCE OF RESEARCH
With their relative ease of acquisition, and the ability to differentiate into a variety of
tissues, DPSC can potentially serve multiple roles in both the regeneration and study of these
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tissues. However, large quantities of functional DPSC must be available before serious research
and therapy are to be considered. With dental pulp presenting a small volume of primary tissue,
the only other way to obtain large quantities of DPSC is through in vitro culture. The mechanism
for this loss of differentiation in DPSC remains largely unknown. While an occasional study may
link the change of a particular gene to increased passaging [2], direct evidence of a relationship
between a gene and changes in DPSC functionality would be of greater benefit to understanding
and preventing this loss of differentiation capability. We believe this study helps to further
understanding of the molecular regulation of differentiation in other tissue derived stem cells.
The finding of miRNAs in regulating differentiation is especially significant, since each miRNA
can regulate multiple genes. This may allow us to establish the molecular regulatory network for
maintaining differentiation potential in ASC.
5.3 FUTURE STUDIES
HspB8 has already been shown to function in concert with other small heat shock
proteins [8, 9]. The possibility that HspB8 works with other proteins to maintain differentiation
should be addressed. In addition, the discovery that miRNAs acting on HspB8 mRNA to inhibit
translation is a novel one, and the interaction of HspB8 transcript with miRNAs is one that
deserves further study. Over 1000 miRNAs have been found in animal cells. One big question is
which miRNAs actually target HspB8 mRNA to down regulate its expression in long-term
cultures of DPSC. In this regard, using the TargetScan miRNA prediction tool, we found 42
potential miRNAs that may target against HspB8 (Table 5.1) [10]. Immediate future studies
would focus on determining which of these miRNAs are elevated in the late passage DPSC, and
which miRNAs can act to down regulate HspB8. In addition, it is also our interest to define the
exact target sites of miRNAs on the 3’UTR of HspB8 mRNA. Since each miRNA can target
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Table 5.1 miRNAs predicted to target HspB8 mRNA
miRNA
Seed match on 3’UTR miRNA Sequence*
rno-miR-3561
138-145
AGACUCACAGAUGGGACCUAU
rno-miR-3562
36-42
AGGGUAGGUCGGUGACGGGGUU
rno-miR-295
54-60
UCUUCACACGGGGUGUAAACUCA
rno-miR-543
92-98
GCUUUUUGUGCGCCCGUUGAA
rno-miR-219-1-3p
93-100
GCCCUGCAGGUCUGCGUUGAGA
rno-miR-3541
114-121
ACGUCACUCCCCCUCCCU
rno-miR-343
116-123
AGACCCGUGUGCCUCCCUCU
rno-miR-3594-5p
137-143
AAGUGUGACGAGACGGGACCC
rno-miR-323
144-150
UCUCCAGCUGGCACAUUACAC
rno-miR-539
158-164
UGUGUGGUUCCUAUUAAAGAGG
rno-miR-3558-3p
166-172
GUGUUUAAGCCUAGAUGUCCCAU
rno-miR-10a-5p
166-172
GUGUUUAAGCCUAGAUGUCCCAU
rno-miR-336
168-174
UCUGAUCUAUACCU---UCCCACU
rno-miR-592
173-179
UGUAGUAGCGUAUAACUGUGUUA
rno-miR-124
199-205
CCGUAAGUGGCGCACGGAAU
rno-miR-215
204-211
ACAGACAGUUUAGUAUCCAGUA
rno-miR-192
204-211
CCGACAGUUAAGUAUCCAGUC
rno-miR-150
216-222
GUGACCAUGUUCCCAACCCUCU
rno-miR-3551-5p
243-250
UACAGUUUUUGUGGUACCACUUCU
rno-miR-3580-5p
275-281
CAGUGGUCUUAUUCAUGUUCGU
rno-miR-194
302-308
AGGUGUACCUCAACGACAAUGU
rno-miR-22
319-325
UGUCAAGAAGUUGACCGUCGAA
rno-miR-431
328-334
ACGUACUGCCGGACGUUCUGU
rno-miR-493
350-356
GACCGUGUGUCAUCUGGAAGU
rno-let-7i
423-429
UUGUCGUGUUUGAUGAUGGAGU
rno-let-7f
423-429
UUGGUAUGUUGGAUGAUGGAGU
rno-let-7c
423-429
UUGGUAUGUUGGAUGAUGGAGU
rno-let-7d
423-429
UUGAUACGUUGGAUGAUGGAGA
rno-let-7a
423-429
UUGAUAUGUUGGAUGAUGGAGU
rno-let-7e
423-429
UUGAUAUGUUGGAGGAUGGAGU
rno-let-7b
423-429
UUGGUGUGUUGGAUGAUGGAGU
rno-miR-98
423-429
UUGUUAUGUUGAAUGAUGGAGU
rno-miR-674-5p
426-432
AUGUGGUGAGGGUAGAGUCACG
rno-miR-3587
427-433
CGUGGUAAACUUU---AGUCACAA
rno-miR-3571
429-435
AUACCUUACAUUUCUUCACACAU
rno-miR-3560
489-495
UUACGUGGGCCCGUUCCUAAAC
rno-miR-3563-3p
497-503
CAAAUGGCAGGGUGUAU
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(Table 5.1 continued)
miRNA
Seed match on 3’UTR miRNA Sequence*
rno-miR-615
531-537
CUAGGCUCGUGGCCCCUGGGGG
rno-miR-3573-5p
573-580
AGGAAAGAUAGUGACGGGGAGU
rno-miR-3583-3p
626-632
GACGUACUUCUCUCUUCAGUCC
rno-miR-674-3p
644-650
AACAAGACUCUACCCUCGACAC
rno-miR-337
806-812
UUUCCGUAGUAUAUC---CUCGACUU
*The miRNA Sequences listed are arranged in a 3’ to 5’ order
more than one gene, another research topic will be to find out if HspB8-targeting miRNAs can
also regulate expression of other genes for maintaining differentiation, and what those genes are.
For example, Zfp423 also reduced expression in the late passage DPSC, and in a pilot study we
noticed that knockdown of its expression also decreased differentiation of early passage DPSC.
In conclusion, this study revealed that DPSC lose differentiation potential around
passages 9 or 11. High level expression of HspB8 is essential for differentiation of DPSC, and
down-regulation of HspB8 in cultured DPSC is likely due to increased expression of miRNAs.
These are novel findings regarding HspB8 and miRNAs on the regulation of stem cell fate. The
potential miRNAs that may regulate HspB8 expression are predicted using a bioinformatics tool.
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APPENDIX A DIFFERENTIATION AND RELATIVE GENE EXPRESSION OF
SIGNIFICANT GENES IN MULTIPLE SERIAL PASSAGES OF DPSC
DPSC L10-7
p3
p5
p9

p11

DPSC L11-27
p3
p5

p9

p11

Differentiation

2

2

1

0

4

3

1

1

Apbb1ip

1.00

0.08

0.01

0.01

1.00

0.30

0.08

0.02

Clgn

1.00

0.08

0.03

0.00

1.00

0.03

0.02

0.01

Colec11

1.00

0.19

0.10

0.12

1.00

0.06

0.09

0.07

Eya2

1.00

0.03

0.00

0.02

1.00

0.06

0.01

0.01

Fam159b

1.00

0.02

0.00

0.00

1.00

0.05

0.01

0.01

Gipc2

1.00

0.34

0.04

0.02

1.00

0.42

0.16

0.14

HspB8

1.00

0.29

0.09

0.36

1.00

0.34

0.12

0.17

Thbd

1.00

0.03

0.00

0.00

1.00

0.02

0.00

0.01

Wif1

1.00

0.04

0.00

0.01

1.00

0.17

0.07

0.33

Zfp423

1.00

0.06

0.03

0.08

1.00

0.26

0.38

0.39
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APPENDIX B ABBREVIATIONS OF GENE NAMES USED IN THIS DISSERTATION
Abbreviation
Acad9
Alx1
Ambn

Arhgap20
Bcrp
BMP4
BMP6
BSP
c-Myc
Clgn
Colec11
Dax1
DMP1
DSPP
Dusp7
Egflam

Full gene name
Acyl-CoA dehydrogenase family, member 9
ALX homeobox 1
Ameloblastin
Amyloid beta (A4) precursor protein-binding, family B, member 1 interacting
protein
Rho GTPase activating protein 20
ATP-binding cassette, sub-family G (WHITE), member 2
Bone Morphogenetic Protein 4
Bone Morphogenetic Protein 6
Integrin-binding sialoprotein (alias: Ibsp)
Myelocytomatosis oncogene
Calmegin
Collectin sub-family member 11
Nuclear receptor subfamily 0, group B, member 1 (alias: Nr0b1)
Dentin matrix acidic phosphoprotein 1
Dentin sialophosphoprotein
Dual specificity phosphatase 7
EGF-like, fibronectin type III and laminin G domains

EGR1
Esrrb
Eya2
Fam159b

Early growth response 1
Estrogen-related receptor beta
Eyes absent homolog 2
Family with sequence similarity 159, member B

FoxM1

Forkhead box M1

FoxO1

Forkhead box O1

FoxO3

Forkhead box O3

FoxO4
Gipc1
Gipc2
HspB1
HspB8
KitL
Klf4
Klf5
LacZ
Lin28

Forkhead box O4
GIPC PDZ domain containing family, member 1
GIPC PDZ domain containing family, member 2
Heat shock protein 1
Heat shock protein B8
KIT ligand
Kruppel-like factor 4
Kruppel-like factor 5
Beta-D-galactosidase
Lin-28 homolog A

Apbb1ip
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(Appendix B continued)
Abbreviation Full gene name
Nifk nucleolar protein interacting with the FHA domain of MKI67
Mki67ip
(Alias: Nifk)
Mmp13
Matrix metallopeptidase 13
Msh2
MutS homolog 2
Mst1
Macrophage stimulating 1 (hepatocyte growth factor-like)
Musashi
Musashi
Nanog
Nanog homeobox
Ocn
Bone gamma-carboxyglutamate (gla) protein (Alias: Bglap)
Oct4
OCT4 Protein
PCOLCE2

Procollagen C-endopeptidase enhancer 2

Runx2
Sall1
Sial
Slc6a15
Sox2
Sp7
Spp1
Tcfap2c
Tcfcp2L1
Thbd
Timp2
Wif1
Wnt16
Zfp143
Zfp219
Zfp423
Zfp462

Runt-related transcription factor 2
Spalt-like transcription factor 1
Integrin-binding sialoprotein (alias: Ibsp)
Solute carrier family 6 (neutral amino acid transporter), member 15
SRY (sex determining region Y)-box 2
Sp7 transcription factor
Secreted phosphoprotein 1
Transcription factor AP-2 gamma
Transcription factor CP2-like 1
Thrombomodulin
TIMP metallopeptidase inhibitor 2
Wnt inhibitory factor 1
Wingless-type MMTV integration site family, member 16
Zinc finger protein 143
Zinc finger protein 219
Zinc finger protein 423
Zinc finger protein 462
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